Table B.1 December 31 Point Prevalence Counts Of Reported ESRD Therapy By Year, By Age, Race, Sex, and Primary Disease Causing ESRD for U.S. Residents By Year, By Region for All ESRD Patients By Year for All ESRD Patients Lost to Followup 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 AGE AT ESRD 0- 4 266 266 270 261 275 291 302 336 381 437 5- 9 469 501 547 591 623 600 621 662 703 718 10-14 820 883 912 977 1022 1083 1138 1225 1340 1392 15-19 1946 1991 2076 2042 2031 2085 2156 2348 2526 2633 20-24 3851 3962 4087 4252 4454 4662 4761 4896 4980 5021 25-29 6708 7070 7498 7878 8022 8191 8292 8605 9041 9386 30-34 9050 9722 10583 11228 12090 12669 13336 14050 14659 14859 35-39 10591 11570 12596 13738 14718 15939 16842 18149 19278 20284 40-44 10029 11296 12951 14729 16431 17883 19230 20624 22696 24184 45-49 9969 11143 12642 13764 15744 17605 19621 22199 25147 27494 50-54 10548 11728 13085 14402 15688 17665 19489 21969 24174 26717 55-59 12008 12806 14026 15413 17012 18727 20299 22476 24819 27011 60-64 13544 14741 16264 17850 19389 20859 22154 24072 26687 28612 65-69 13195 14651 16825 18810 20738 23057 25082 27252 29197 30545 70-74 10002 11068 12960 15118 17623 19920 22076 24704 26645 28004 75-79 6773 7690 9062 10248 11866 13496 14782 16807 18814 20566 80-84 3049 3559 4299 5185 6007 7114 8115 9248 10310 11151 85 plus 1004 1246 1565 1954 2373 2801 3295 3773 4346 4918 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 123822 135893 152248 168440 186106 204647 221591 243395 265743 283932 RACE White 81198 88603 98437 108426 119213 130006 139639 151831 163641 173443 Black 37032 40995 46519 51864 57735 64344 70291 77754 85220 91580 Asian 3381 3848 4202 4707 5346 6012 6895 7953 9103 9863 Native Amer. 1352 1590 1897 2164 2445 2849 3104 3502 4017 4504 Other 634 649 613 643 688 724 842 1135 2072 3124 Unknown 225 208 580 636 679 712 820 1220 1690 1418 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 123822 135893 152248 168440 186106 204647 221591 243395 265743 283932 SEX Male 66770 73108 81711 90613 100308 110187 119496 131137 142969 153381 Female 57052 62785 70537 77827 85798 94460 102095 112258 122774 130551 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 123822 135893 152248 168440 186106 204647 221591 243395 265743 283932 PRIMARY DIAGNOSIS Diabetes 26074 30257 36176 42472 49668 57134 63541 72782 83300 92211 Hypertension 28088 31545 36297 41097 46279 52083 56651 62993 66791 69538 Glomeruloneph. 26337 28612 31268 33765 36315 38814 41273 44463 47729 50378 Cystic Kidney 7142 7684 8286 8932 9685 10457 11135 11968 12848 13454 Other Urologic 2322 2517 2760 3017 3361 3725 3988 4390 4983 5547 Other Cause 15568 16796 18560 20001 21704 23424 24871 26936 30110 32301 Unknown Cause 9609 10113 10343 10746 11418 12162 12681 13453 13832 14209 Missing Cause 8682 8369 8558 8410 7676 6848 7451 6410 6150 6294 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 123822 135893 152248 168440 186106 204647 221591 243395 265743 283932 U.S. 123737 135740 151935 168060 185591 203918 220480 240898 262853 281896 Presumed U.S. 85 153 313 380 515 729 1111 2497 2890 2036 Puerto Rico 1470 1596 1819 2020 2183 2422 2582 2835 3006 3237 Other non-U.S. 91 107 126 151 177 213 228 256 297 346 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 125383 137596 154193 170611 188466 207282 224401 246486 269046 287515 Lost to Followup 8814 9362 8906 9312 10222 11206 12020 13107 14463 18348 Patients alive on ESRD therapy and not lost to followup on December 31 of each year (with exception of last row detailing Lost to Followup). Includes Medicare patients only. Age is as of December 31. Table B.2 Counts Of U.S. Patients Lost to Followup on December 31 By Year, By Age, Race, Sex, and Primary Disease Causing ESRD 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 AGE AT ESRD 0- 4 6 13 10 16 20 25 19 18 22 32 5- 9 34 33 34 30 33 35 40 46 51 63 10-14 49 43 37 45 50 51 55 67 55 74 15-19 114 119 116 112 111 97 97 82 95 115 20-24 205 189 150 167 180 183 177 185 189 256 25-29 439 397 349 322 319 317 314 287 309 454 30-34 679 667 614 606 595 588 569 580 583 704 35-39 810 811 802 811 872 859 870 867 894 1156 40-44 745 777 781 846 911 983 1022 1110 1194 1472 45-49 727 792 739 744 809 911 974 1082 1218 1588 50-54 704 700 668 707 767 853 892 940 1070 1512 55-59 821 832 717 725 803 836 886 995 1105 1444 60-64 941 991 901 926 993 1096 1111 1144 1195 1713 65-69 942 1034 948 1002 1082 1224 1337 1497 1614 1995 70-74 693 854 860 907 1089 1268 1453 1656 1902 2186 75-79 498 619 655 708 824 957 1097 1268 1470 1818 80-84 266 339 368 437 516 602 714 815 945 1089 85 plus 141 152 157 201 248 321 393 468 552 677 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 8814 9362 8906 9312 10222 11206 12020 13107 14463 18348 RACE White 6125 6406 6348 6575 7066 7706 8185 8868 9574 11418 Black 2380 2600 2196 2326 2610 2791 2989 3221 3665 5056 Asian 177 209 233 263 291 355 403 464 565 872 Native Amer. 75 84 75 93 109 124 132 142 157 236 Other 28 30 22 24 22 23 20 25 31 59 Unknown 29 33 32 31 124 207 291 387 471 707 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 8814 9362 8906 9312 10222 11206 12020 13107 14463 18348 SEX Male 5276 5623 5494 5707 6142 6640 7102 7603 8258 10086 Female 3538 3739 3412 3605 4080 4566 4918 5504 6205 8262 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 8814 9362 8906 9312 10222 11206 12020 13107 14463 18348 PRIMARY DIAGNOSIS Diabetes 898 1049 1052 1135 1346 1587 1826 2183 2609 3854 Hypertension 1813 2006 1874 1988 2238 2560 2795 3099 3507 4633 Glomeruloneph. 2245 2286 2232 2290 2399 2499 2567 2598 2740 3228 Cystic Kidney 359 368 307 307 311 330 338 376 391 487 Other Urologic 165 187 182 187 212 188 220 243 282 349 Other Cause 1321 1454 1419 1555 1711 1898 2057 2278 2459 3052 Unknown Cause 1115 1174 1116 1137 1176 1224 1236 1290 1355 1562 Missing Cause 898 838 724 713 829 920 981 1040 1120 1183 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 8814 9362 8906 9312 10222 11206 12020 13107 14463 18348 Patients lost to followup on December 31 of each year. Includes Medicare patients only. Age is as of December 31. Table B.3 Annual U.S. Period Prevalence Counts Of Reported ESRD Therapy By Year, By Age, Race, Sex, and Primary Disease Causing ESRD for U.S. Residents 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 AGE AT ESRD 0- 4 330 327 348 333 355 351 363 394 465 522 5- 9 497 544 571 646 646 665 669 736 756 780 10-14 899 941 992 1070 1127 1157 1234 1303 1442 1478 15-19 2127 2223 2340 2324 2264 2326 2345 2539 2751 2904 20-24 4264 4378 4506 4601 4851 5061 5255 5420 5578 5510 25-29 7227 7743 8222 8641 8804 9020 9117 9439 9760 10158 30-34 9898 10563 11413 12168 13040 13785 14414 15263 16071 16256 35-39 11396 12532 13601 14704 15839 17205 18316 19590 21000 22008 40-44 10971 12059 13855 15837 17953 19372 20816 22424 24498 26183 45-49 10863 12313 13888 15212 16825 19328 21269 24088 27221 30284 50-54 12139 13319 14778 16308 17607 19554 21653 24451 27173 29106 55-59 14264 15324 16643 17935 19685 21739 23539 26036 28643 30864 60-64 16451 18084 19805 21639 23525 25288 26884 29079 31901 33901 65-69 16670 18616 21417 23899 26383 29065 31558 34257 36594 38185 70-74 13335 14762 16962 19595 22613 25933 28826 31982 34710 36580 75-79 9114 10506 12417 14075 15959 18333 20259 22390 25205 27501 80-84 4175 5021 6107 7147 8408 9770 11222 12829 14308 15665 85 plus 1434 1794 2274 2798 3371 4052 4738 5460 6288 7129 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 146054 161049 180139 198932 219255 242004 262477 287680 314364 335014 RACE White 96684 106079 117466 129552 142211 155972 167730 181849 196154 207925 Black 42939 47624 54145 59962 66621 74252 81394 90022 98878 105653 Asian 3852 4451 4749 5310 5954 6724 7643 8957 10262 11210 Native Amer. 1580 1849 2184 2523 2838 3287 3619 4055 4657 5217 Other 730 789 755 686 737 779 897 1219 2252 3390 Unknown 269 257 840 899 894 990 1194 1578 2161 1619 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 146054 161049 180139 198932 219255 242004 262477 287680 314364 335014 SEX Male 79020 86834 96803 106997 117939 130084 141022 154529 168516 180432 Female 67034 74215 83336 91935 101316 111920 121455 133151 145848 154582 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 146054 161049 180139 198932 219255 242004 262477 287680 314364 335014 PRIMARY DIAGNOSIS Diabetes 32580 37703 44597 52299 60911 70262 78225 88852 101743 112999 Hypertension 34083 38624 44424 50169 56453 63515 69213 76625 81398 84518 Glomeruloneph. 29076 31719 34554 37276 39820 42622 45177 48603 52250 55146 Cystic Kidney 7769 8420 9050 9743 10459 11292 12067 12878 13907 14549 Other Urologic 2756 2991 3277 3556 3884 4272 4579 5014 5706 6384 Other Cause 17930 19276 21237 22953 24865 26974 28645 31054 34884 37746 Unknown Cause 11178 12076 12439 12646 13323 14312 14816 15480 16091 16494 Missing Cause 10682 10240 10561 10290 9540 8755 9755 9174 8385 7178 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 146054 161049 180139 198932 219255 242004 262477 287680 314364 335014 Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup at any time during each year. Includes Medicare patients only. Age is as of July 1. Table B.4 December 31, 1996 Point Prevalence Counts of Reported ESRD Therapy By Age, Sex, and Primary Disease Causing ESRD For Patients Residing Outside 50 States and D.C. --------------------------------------------------- | |Puerto Rico |Other non-US| | |------------+------------| | | Count | Count | |-----------------------+------------+------------| |ALL PATIENTS | 3237| 346| |AGE AT ESRD | | | |0-19 | 46| 7| |20-44 | 763| 70| |45-64 | 1556| 186| |65-74 | 582| 66| |75 plus | 290| 17| |SEX | | | |Male | 1950| 183| |Female | 1287| 163| |PRIMARY DIAGNOSIS | | | |Diabetes | 1231| 159| |Hypertension | 574| 87| |Glomeruloneph. | 753| 45| |Cystic Kidney | 130| 9| |Other Urologic | 75| 11| |Other Cause | 263| 18| |Unknown Cause | 163| 10| |Missing Cause | 48| 7| --------------------------------------------------- Patients alive on ESRD therapy and not lost to followup on December 31, 1996. Includes Medicare patients only. Age is as of December 31. Table B.5 December 31 Point Prevalence Rates Per Million Population Of Reported ESRD Therapy By Year, By Age, Race, Sex, and Primary Disease Causing ESRD Unadjusted 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 AGE AT ESRD 0- 4 15 14 14 14 14 15 15 17 20 23 5- 9 27 28 30 33 34 33 33 35 36 37 10-14 50 53 54 56 57 59 61 65 71 73 15-19 105 109 116 117 118 121 123 131 137 139 20-24 193 204 213 222 233 246 255 268 280 290 25-29 308 327 350 375 393 412 428 451 476 493 30-34 427 451 486 509 545 570 601 638 678 704 35-39 563 602 639 678 707 747 773 820 859 893 40-44 631 682 745 806 875 941 988 1032 1105 1146 45-49 790 845 928 986 1069 1125 1203 1300 1401 1453 50-54 968 1056 1159 1252 1323 1425 1503 1637 1753 1898 55-59 1107 1205 1335 1475 1627 1769 1878 2041 2211 2349 60-64 1256 1371 1525 1684 1845 2018 2181 2392 2662 2869 65-69 1349 1481 1679 1871 2074 2308 2512 2741 2948 3092 70-74 1291 1409 1628 1858 2109 2332 2545 2814 3028 3199 75-79 1159 1289 1489 1648 1873 2098 2266 2535 2776 2952 80-84 835 946 1109 1300 1471 1697 1888 2098 2286 2422 85 plus 352 426 520 630 731 832 945 1049 1172 1289 0-19 49 51 53 54 54 55 57 61 65 68 20-44 412 443 480 515 550 585 616 654 697 728 45-64 1020 1104 1216 1321 1427 1529 1623 1759 1903 2016 65-74 1324 1449 1656 1865 2090 2319 2527 2775 2985 3142 75 plus 877 987 1150 1307 1482 1673 1830 2038 2232 2381 RACE White 395 428 472 516 562 608 648 699 747 786 Black 1254 1370 1533 1683 1840 2016 2169 2365 2559 2717 Other 664 708 780 831 895 966 1055 1207 1426 1547 SEX Male 563 611 676 741 811 880 944 1025 1107 1176 Female 457 498 555 606 661 720 771 840 910 960 PRIMARY DIAGNOSIS Diabetes 107 123 146 169 196 223 245 278 315 346 Hypertension 115 128 146 164 183 203 219 241 253 261 Glomeruloneph. 108 116 126 135 143 151 159 170 181 189 Cystic Kidney 29 31 33 36 38 41 43 46 49 50 Other Urologic 10 10 11 12 13 15 15 17 19 21 Other Cause 64 68 75 80 86 91 96 103 114 121 Unknown Cause 39 41 42 43 45 47 49 51 52 53 Missing Cause 36 34 34 34 30 27 29 25 23 24 CRUDE RATE 509 553 614 672 734 798 855 930 1006 1065 Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Rates are not reported for some race categories for reasons discussed in notes at beginning of this Section. The population base is the U.S. resident population on December 31 of each year. Age is as of December 31. See Table B.8 and following for rates adjusted for age, race, and sex. Table B.6 December 31 Point Prevalence Counts Of Reported ESRD Therapy By Year, By Age, Race, Sex, and Primary Disease Causing ESRD After Dropping Patients With Race "Other" and "Unknown" 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 AGE AT ESRD 0- 4 265 265 270 260 272 289 298 325 354 406 5- 9 466 497 542 586 616 593 615 650 687 692 10-14 814 879 908 969 1014 1074 1123 1202 1307 1343 15-19 1927 1969 2056 2021 2009 2061 2130 2315 2477 2572 20-24 3819 3924 4052 4219 4428 4637 4733 4841 4899 4907 25-29 6643 7018 7444 7823 7960 8125 8227 8521 8921 9239 30-34 8959 9624 10484 11133 11994 12573 13246 13936 14487 14629 35-39 10488 11467 12479 13623 14594 15823 16712 17964 19055 20005 40-44 9940 11199 12848 14614 16312 17749 19091 20438 22428 23853 45-49 9896 11053 12556 13672 15639 17489 19491 22028 24859 27118 50-54 10485 11661 13016 14325 15601 17574 19369 21804 23882 26295 55-59 11931 12740 13953 15344 16946 18653 20211 22321 24510 26592 60-64 13469 14676 16191 17768 19308 20779 22064 23931 26396 28182 65-69 13131 14589 16679 18655 20570 22865 24858 26916 28636 29996 70-74 9957 11024 12822 14955 17449 19751 21864 24415 26213 27540 75-79 6737 7659 8956 10144 11749 13376 14648 16600 18490 20216 80-84 3037 3550 4258 5130 5940 7051 8012 9125 10124 10971 85 plus 999 1242 1541 1920 2338 2749 3237 3708 4256 4834 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 122963 135036 151055 167161 184739 203211 219929 241040 261981 279390 RACE White 81198 88603 98437 108426 119213 130006 139639 151831 163641 173443 Black 37032 40995 46519 51864 57735 64344 70291 77754 85220 91580 Asian 3381 3848 4202 4707 5346 6012 6895 7953 9103 9863 Native Amer. 1352 1590 1897 2164 2445 2849 3104 3502 4017 4504 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 122963 135036 151055 167161 184739 203211 219929 241040 261981 279390 SEX Male 66315 72656 81105 89972 99612 109460 118705 130021 141119 151121 Female 56648 62380 69950 77189 85127 93751 101224 111019 120862 128269 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 122963 135036 151055 167161 184739 203211 219929 241040 261981 279390 PRIMARY DIAGNOSIS Diabetes 25985 30161 36089 42375 49558 56993 63322 72397 82411 90817 Hypertension 28013 31464 36210 41005 46176 51960 56495 62709 66347 68969 Glomeruloneph. 26145 28398 31049 33532 36069 38563 40996 44118 47214 49721 Cystic Kidney 7118 7659 8260 8904 9653 10425 11097 11919 12776 13366 Other Urologic 2314 2509 2752 3008 3348 3712 3970 4358 4936 5481 Other Cause 15499 16725 18490 19929 21625 23337 24771 26773 29850 31953 Unknown Cause 9484 9988 10234 10633 11300 12043 12559 13298 13641 13980 Missing Cause 8405 8132 7971 7775 7010 6178 6719 5468 4806 5103 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 122963 135036 151055 167161 184739 203211 219929 241040 261981 279390 Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Age is as of December 31. Table B.7 Percent Decrease In December 31 Point Prevalence Counts Of Reported ESRD Therapy By Year, By Age, Race, Sex, and Primary Disease Causing ESRD After Dropping Patients With Race "Other" and "Unknown" 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 AGE AT ESRD 0- 4 0.4 0.4 0.0 0.4 1.1 0.7 1.3 3.3 7.1 7.1 5- 9 0.6 0.8 0.9 0.8 1.1 1.2 1.0 1.8 2.3 3.6 10-14 0.7 0.5 0.4 0.8 0.8 0.8 1.3 1.9 2.5 3.5 15-19 1.0 1.1 1.0 1.0 1.1 1.2 1.2 1.4 1.9 2.3 20-24 0.8 1.0 0.9 0.8 0.6 0.5 0.6 1.1 1.6 2.3 25-29 1.0 0.7 0.7 0.7 0.8 0.8 0.8 1.0 1.3 1.6 30-34 1.0 1.0 0.9 0.8 0.8 0.8 0.7 0.8 1.2 1.5 35-39 1.0 0.9 0.9 0.8 0.8 0.7 0.8 1.0 1.2 1.4 40-44 0.9 0.9 0.8 0.8 0.7 0.7 0.7 0.9 1.2 1.4 45-49 0.7 0.8 0.7 0.7 0.7 0.7 0.7 0.8 1.1 1.4 50-54 0.6 0.6 0.5 0.5 0.6 0.5 0.6 0.8 1.2 1.6 55-59 0.6 0.5 0.5 0.4 0.4 0.4 0.4 0.7 1.2 1.6 60-64 0.6 0.4 0.4 0.5 0.4 0.4 0.4 0.6 1.1 1.5 65-69 0.5 0.4 0.9 0.8 0.8 0.8 0.9 1.2 1.9 1.8 70-74 0.4 0.4 1.1 1.1 1.0 0.8 1.0 1.2 1.6 1.7 75-79 0.5 0.4 1.2 1.0 1.0 0.9 0.9 1.2 1.7 1.7 80-84 0.4 0.3 1.0 1.1 1.1 0.9 1.3 1.3 1.8 1.6 85 plus 0.5 0.3 1.5 1.7 1.5 1.9 1.8 1.7 2.1 1.7 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 0.7 0.6 0.8 0.8 0.7 0.7 0.8 1.0 1.4 1.6 SEX Male 0.7 0.6 0.7 0.7 0.7 0.7 0.7 0.9 1.3 1.5 Female 0.7 0.6 0.8 0.8 0.8 0.8 0.9 1.1 1.6 1.7 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 0.7 0.6 0.8 0.8 0.7 0.7 0.8 1.0 1.4 1.6 PRIMARY DIAGNOSIS Diabetes 0.3 0.3 0.2 0.2 0.2 0.2 0.3 0.5 1.1 1.5 Hypertension 0.3 0.3 0.2 0.2 0.2 0.2 0.3 0.5 0.7 0.8 Glomeruloneph. 0.7 0.7 0.7 0.7 0.7 0.6 0.7 0.8 1.1 1.3 Cystic Kidney 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.6 0.7 Other Urologic 0.3 0.3 0.3 0.3 0.4 0.3 0.5 0.7 0.9 1.2 Other Cause 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.6 0.9 1.1 Unknown Cause 1.3 1.2 1.1 1.1 1.0 1.0 1.0 1.2 1.4 1.6 Missing Cause 3.2 2.8 6.9 7.6 8.7 9.8 9.8 14.7 21.9 18.9 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 0.7 0.6 0.8 0.8 0.7 0.7 0.8 1.0 1.4 1.6 Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Note that the Missing disease group is disproportionately represented. Table B.8 December 31 Point Prevalence Rates Per Million Population Of Reported ESRD Therapy By Year, By Age, Race, Sex, and Primary Disease Causing ESRD Adjusted for Age, Race, and Sex 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 AGE AT ESRD 0- 4 14 14 14 14 14 15 15 16 18 21 5- 9 26 28 30 32 33 32 32 34 35 35 10-14 49 52 53 55 56 58 60 63 68 69 15-19 103 106 113 114 115 117 118 125 131 132 20-24 189 199 208 217 227 239 247 257 265 273 25-29 304 323 346 370 385 403 418 439 460 475 30-34 425 448 482 506 540 564 595 630 665 685 35-39 570 607 642 681 707 746 769 812 849 880 40-44 662 711 776 834 898 959 1003 1043 1111 1147 45-49 831 892 984 1044 1136 1198 1275 1369 1462 1505 50-54 1035 1131 1240 1337 1411 1524 1614 1757 1873 2018 55-59 1219 1322 1460 1606 1768 1920 2036 2200 2366 2509 60-64 1414 1544 1709 1883 2052 2239 2405 2620 2889 3091 65-69 1554 1700 1914 2126 2346 2594 2813 3037 3223 3368 70-74 1504 1644 1889 2151 2436 2699 2952 3261 3492 3667 75-79 1371 1535 1756 1946 2212 2484 2688 3000 3254 3435 80-84 1061 1187 1378 1621 1834 2136 2348 2606 2821 2982 85 plus 506 602 720 863 1014 1145 1280 1413 1553 1729 0-19 48 50 52 53 54 55 56 60 63 64 20-44 430 458 491 521 552 582 606 636 670 692 45-64 1125 1222 1348 1467 1592 1720 1833 1986 2147 2280 65-74 1529 1672 1901 2138 2391 2646 2883 3149 3357 3518 75 plus 979 1108 1285 1477 1687 1921 2105 2340 2543 2715 RACE White 393 425 467 508 552 593 629 676 720 754 Black 1623 1769 1979 2171 2372 2594 2780 3016 3234 3404 Asian 697 748 775 820 877 938 1031 1138 1250 1291 Native Amer. 1030 1162 1365 1514 1671 1928 2051 2256 2524 2761 SEX Male 624 674 742 811 884 955 1018 1097 1170 1233 Female 447 486 537 583 633 685 729 787 844 883 PRIMARY DIAGNOSIS Diabetes 112 128 151 174 200 226 247 278 312 339 Hypertension 124 137 154 171 189 208 222 242 251 256 Glomeruloneph. 112 120 129 137 145 153 160 170 179 185 Cystic Kidney 31 32 35 37 39 42 43 46 48 50 Other Urologic 10 10 11 12 13 15 15 17 19 21 Other Cause 64 69 75 80 86 92 96 103 113 119 Unknown Cause 41 42 42 44 46 48 49 51 52 52 Missing Cause 36 34 33 32 28 25 26 21 18 19 CRUDE RATE 505 550 609 667 729 793 849 921 992 1048 ADJUSTED RATE 529 573 631 688 747 808 860 928 992 1041 Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. All rates are therefore slightly low but are consistently defined and are comparable. The bias introduced by excluding the cases with race Other or Unknown is unpredictable. Age is as of December 31 of each year. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. Rates by age are adjusted for race and sex. Rates by sex are adjusted for race and age. Rates by race are adjusted for sex and age. Rates by primary disease and "adjusted rate" row are adjusted for age, race, and sex. The "Crude rate" row is not adjusted. Table B.9 December 31 Point Prevalence Counts Of Reported ESRD Therapy By Age, By Sex, By Race 1991-1993 ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 478 99 * * 585| 224 37 * * 274| 702 136 10 11 859| | 5- 9 | 952 219 27 13 1211| 505 88 19 * 613| 1457 307 46 14 1824| | 10-14 | 1501 334 44 25 1904| 1031 194 56 26 1307| 2532 528 100 51 3211| | 15-19 | 2416 820 111 61 3408| 2015 619 111 47 2792| 4431 1439 222 108 6200| | 20-24 | 5046 2264 264 93 7667| 4194 1630 218 89 6131| 9240 3894 482 182 13798| | 25-29 | 9099 3812 427 119 13457| 7457 2918 355 125 10855| 16556 6730 782 244 24312| | 30-34 | 14759 5744 611 255 21369| 11359 4356 519 210 16444| 26118 10100 1130 465 37813| | 35-39 | 18088 8915 843 275 28121| 12506 5593 706 203 19008| 30594 14508 1549 478 47129| | 40-44 | 19934 11258 905 355 32452| 13170 6500 802 228 20700| 33104 17758 1707 583 53152| | 45-49 | 19127 10764 847 469 31207| 13133 7145 787 347 21412| 32260 17909 1634 816 52619| | 50-54 | 17767 10464 943 543 29717| 13072 8496 768 491 22827| 30839 18960 1711 1034 52544| | 55-59 | 17819 10517 879 545 29760| 14341 10380 781 548 26050| 32160 20897 1660 1093 55810| | 60-64 | 19578 10122 856 469 31025| 17566 12092 849 619 31126| 37144 22214 1705 1088 62151| | 65-69 | 22711 8990 912 368 32981| 20538 13137 1033 604 35312| 43249 22127 1945 972 68293| | 70-74 | 21049 6598 764 229 28640| 18533 10571 884 436 30424| 39582 17169 1648 665 59064| | 75-79 | 15227 3852 497 147 19723| 12697 6547 602 204 20050| 27924 10399 1099 351 39773| | 80-84 | 8146 1906 323 70 10445| 6934 3215 285 124 10558| 15080 5121 608 194 21003| | 85 plus | 3172 779 126 28 4105| 2714 1395 89 21 4219| 5886 2174 215 49 8324| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 216869 97457 9383 4068 327777|171989 94913 8870 4330 280102|388858 192370 18253 8398 607879| ----------------------------------------------------------------------------------------------------------------------- 1994-1996 ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 557 136 14 * 715| 289 65 12 * 370| 846 201 26 12 1085| | 5- 9 | 1033 247 17 17 1314| 562 111 26 16 715| 1595 358 43 33 2029| | 10-14 | 1754 481 70 32 2337| 1181 257 59 18 1515| 2935 738 129 50 3852| | 15-19 | 2852 1099 132 64 4147| 2262 751 131 73 3217| 5114 1850 263 137 7364| | 20-24 | 5017 2612 303 118 8050| 4158 2019 318 102 6597| 9175 4631 621 220 14647| | 25-29 | 9378 4917 533 169 14997| 7408 3726 393 157 11684| 16786 8643 926 326 26681| | 30-34 | 16005 7167 763 243 24178| 12312 5665 647 250 18874| 28317 12832 1410 493 43052| | 35-39 | 21324 10589 1000 398 33311| 15002 7433 964 314 23713| 36326 18022 1964 712 57024| | 40-44 | 24318 14133 1246 529 40226| 16068 8935 1122 368 26493| 40386 23068 2368 897 66719| | 45-49 | 25946 15966 1294 733 43939| 17843 10440 1257 526 30066| 43789 26406 2551 1259 74005| | 50-54 | 24442 14398 1361 772 40973| 17644 11562 1144 658 31008| 42086 25960 2505 1430 71981| | 55-59 | 23495 14023 1409 763 39690| 18484 13293 1154 802 33733| 41979 27316 2563 1565 73423| | 60-64 | 24867 13188 1338 689 40082| 20944 15410 1219 854 38427| 45811 28598 2557 1543 78509| | 65-69 | 27859 11647 1312 590 41408| 25311 16465 1517 847 44140| 53170 28112 2829 1437 85548| | 70-74 | 27503 8834 1293 345 37975| 23843 14309 1396 645 40193| 51346 23143 2689 990 78168| | 75-79 | 21053 5349 919 212 27533| 17395 8975 1047 356 27773| 38448 14324 1966 568 55306| | 80-84 | 11991 2643 527 87 15248| 9824 4435 555 158 14972| 21815 7078 1082 245 30220| | 85 plus | 4743 1125 228 42 6138| 4248 2149 199 64 6660| 8991 3274 427 106 12798| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 274137 128554 13759 5811 422261|214778 126000 13160 6212 360150|488915 254554 26919 12023 782411| ----------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table B.10 December 31 Point Prevalence Rates Per Million Population Of Reported ESRD Therapy Specific Rates By Sex, By Race, By Age, And Rates Adjusted For Age, Race, And Sex 1991-1993 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 20 21 * * | * * * * | 14 14 * 17 | 19 * | 14 | | 5- 9 | 42 51 26 39 | 23 21 19 * | 32 35 23 20 | 42 22 | 32 | | 10-14 | 66 78 43 75 | 48 46 57 80 | 57 62 50 78 | 67 48 | 58 | | 15-19 | 112 202 114 210 | 100 156 120 168 | 106 178 117 188 | 124 108 | 116 | | 20-24 | 214 571 225 315 | 188 398 195 329 | 201 483 209 322 | 260 216 | 237 | | 25-29 | 368 988 375 424 | 310 691 299 466 | 338 837 336 446 | 447 359 | 402 | | 30-34 | 530 1456 515 917 | 414 973 413 742 | 471 1209 462 828 | 649 487 | 566 | | 35-39 | 675 2437 768 1108 | 471 1341 589 781 | 570 1875 677 939 | 903 587 | 740 | | 40-44 | 827 3718 955 1680 | 545 1849 737 1022 | 683 2760 841 1344 | 1202 720 | 953 | | 45-49 | 963 4952 1178 2858 | 650 2756 978 2003 | 801 3820 1074 2417 | 1487 937 | 1202 | | 50-54 | 1131 6072 1739 4375 | 802 4029 1312 3659 | 961 5020 1516 4002 | 1801 1249 | 1516 | | 55-59 | 1336 7414 2124 5609 | 1009 5756 1638 5153 | 1168 6561 1871 5367 | 2166 1665 | 1908 | | 60-64 | 1522 7964 2596 6027 | 1230 7195 1965 7000 | 1374 7571 2271 6516 | 2413 2060 | 2231 | | 65-69 | 1889 7988 3389 5951 | 1412 8572 2862 8162 | 1646 8279 3112 7071 | 2746 2425 | 2584 | | 70-74 | 2111 8031 3747 5150 | 1426 8646 3439 7552 | 1759 8336 3555 6360 | 2938 2459 | 2695 | | 75-79 | 2172 6990 3899 5114 | 1216 7040 3722 4894 | 1682 7012 3790 4991 | 2863 2071 | 2461 | | 80-84 | 2019 6109 4339 4240 | 934 5321 3320 4599 | 1461 5695 3800 4413 | 2631 1601 | 2106 | | 85 plus | 1251 3505 2693 2275 | 407 2598 1359 869 | 817 3035 1995 1537 | 1591 719 | 1146 | | All Age | 689 2148 756 1262 | 526 1885 679 1322 | 606 2010 717 1292 | 872 711 | 790 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 710 2918 1057 1893 | 493 2261 859 1864 | 591 2582 948 1883 | 952 682 | 804 | ------------------------------------------------------------------------------------------------------------------------- 1994-1996 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 23 29 10 * | 12 14 * * | 18 22 10 19 | 23 13 | 18 | | 5- 9 | 44 53 14 49 | 25 24 24 48 | 34 38 19 48 | 44 25 | 34 | | 10-14 | 75 109 61 89 | 53 60 53 51 | 64 84 57 70 | 79 54 | 66 | | 15-19 | 125 252 124 202 | 106 177 128 237 | 115 213 126 221 | 141 117 | 129 | | 20-24 | 228 674 257 408 | 201 508 275 373 | 214 589 266 391 | 287 244 | 265 | | 25-29 | 401 1317 429 583 | 325 914 293 587 | 362 1111 359 584 | 519 400 | 458 | | 30-34 | 597 1806 600 863 | 467 1263 473 898 | 531 1529 535 882 | 753 572 | 659 | | 35-39 | 758 2676 814 1490 | 541 1661 727 1151 | 647 2156 769 1315 | 1008 694 | 846 | | 40-44 | 942 4158 1141 2288 | 624 2283 911 1503 | 779 3196 1022 1883 | 1366 850 | 1100 | | 45-49 | 1139 6039 1443 3912 | 773 3318 1217 2664 | 951 4638 1325 3262 | 1788 1124 | 1445 | | 50-54 | 1403 7668 2095 5605 | 978 5006 1590 4411 | 1185 6302 1832 4985 | 2251 1536 | 1882 | | 55-59 | 1669 9266 2819 7283 | 1237 6859 2076 6927 | 1447 8029 2433 7085 | 2714 2023 | 2357 | | 60-64 | 2003 10317 3495 8396 | 1535 9075 2541 9128 | 1765 9680 3000 8765 | 3160 2588 | 2866 | | 65-69 | 2328 9827 4334 9115 | 1792 10373 3588 10974 | 2055 10103 3949 10055 | 3404 3018 | 3209 | | 70-74 | 2668 10396 5376 6848 | 1799 11409 4374 10298 | 2224 10910 4857 8593 | 3776 3176 | 3473 | | 75-79 | 2787 8973 6134 6631 | 1605 9337 5140 7818 | 2180 9150 5608 7208 | 3716 2758 | 3229 | | 80-84 | 2676 8118 5919 4317 | 1254 7011 4921 5127 | 1947 7552 5377 4719 | 3489 2144 | 2803 | | 85 plus | 1677 4571 3687 2674 | 585 3590 2268 1976 | 1117 4061 2935 2325 | 2118 1035 | 1565 | | All Age | 849 2711 989 1718 | 643 2401 890 1810 | 744 2548 938 1764 | 1089 890 | 987 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 864 3612 1379 2505 | 596 2841 1102 2499 | 716 3218 1226 2513 | 1166 838 | 987 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995 U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.11 Standard Errors For Adjusted December 31 Point Prevalence Rates Per Million Population Of Reported ESRD Therapy By Sex, By Race, By Age Adjusted For Age, Race, And Sex 1991-1993 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 0.9 2.1 * * | 0.6 1.3 * * | 0.5 1.2 1.4 5.1 | 0.8 0.5 | 0.4 | | 5- 9 | 1.3 3.4 5.1 10.8 | 1.0 2.2 4.5 * | 0.8 2.0 3.4 5.5 | 1.2 0.9 | 0.7 | | 10-14 | 1.7 4.2 6.5 15.0 | 1.5 3.3 7.6 15.7 | 1.1 2.7 5.0 10.9 | 1.5 1.3 | 1.0 | | 15-19 | 2.2 7.0 10.8 26.9 | 2.2 6.2 11.3 24.6 | 1.6 4.7 7.8 18.1 | 2.1 2.0 | 1.4 | | 20-24 | 3.0 12.0 13.8 32.7 | 2.9 9.8 13.2 34.9 | 2.0 7.7 9.5 23.9 | 2.9 2.7 | 2.0 | | 25-29 | 3.8 16.0 18.1 38.9 | 3.5 12.8 15.9 41.7 | 2.6 10.2 12.0 28.5 | 3.8 3.4 | 2.5 | | 30-34 | 4.3 19.2 20.8 57.4 | 3.8 14.7 18.1 51.2 | 2.9 12.0 13.7 38.4 | 4.4 3.8 | 2.9 | | 35-39 | 5.0 25.8 26.4 66.8 | 4.2 17.9 22.2 54.8 | 3.2 15.5 17.2 42.9 | 5.3 4.2 | 3.4 | | 40-44 | 5.8 35.0 31.7 89.1 | 4.7 22.9 26.0 67.7 | 3.7 20.7 20.4 55.6 | 6.7 5.0 | 4.1 | | 45-49 | 6.9 47.7 40.5 132.0 | 5.6 32.6 34.8 107.5 | 4.4 28.6 26.6 84.6 | 8.5 6.4 | 5.2 | | 50-54 | 8.4 59.3 56.6 187.7 | 7.0 43.7 47.3 165.1 | 5.4 36.5 36.7 124.5 | 10.5 8.3 | 6.6 | | 55-59 | 10.0 72.3 71.6 240.2 | 8.4 56.5 58.6 220.1 | 6.5 45.6 46.0 162.4 | 12.7 10.3 | 8.1 | | 60-64 | 10.8 79.1 88.7 278.3 | 9.2 65.4 67.4 281.3 | 7.1 51.1 55.4 197.7 | 14.0 11.8 | 9.1 | | 65-69 | 12.5 84.2 112.2 310.2 | 9.8 74.7 89.0 332.1 | 7.9 56.1 71.1 227.3 | 15.6 13.1 | 10.1 | | 70-74 | 14.5 98.8 135.5 340.3 | 10.4 84.1 115.6 361.6 | 8.8 64.6 88.1 248.2 | 18.2 14.6 | 11.6 | | 75-79 | 17.6 112.6 174.9 421.8 | 10.7 87.0 151.7 342.6 | 10.2 70.7 115.0 270.0 | 21.6 15.4 | 13.1 | | 80-84 | 22.3 139.9 241.4 506.8 | 11.2 93.8 196.7 413.0 | 12.3 83.4 154.6 325.5 | 27.3 16.9 | 15.8 | | 85 plus | 22.2 125.6 239.9 430.1 | 7.8 69.5 144.0 189.7 | 11.5 70.8 137.7 229.5 | 25.9 12.1 | 14.0 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1.5 9.6 11.8 31.6 | 1.1 7.3 9.6 29.1 | 0.9 5.9 7.5 21.4 | 1.6 1.2 | 1.0 | ------------------------------------------------------------------------------------------------------------------------- 1994-1996 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 0.9 2.5 2.9 * | 0.7 1.8 2.8 * | 0.6 1.5 2.0 5.6 | 0.8 0.6 | 0.5 | | 5- 9 | 1.3 3.3 3.6 11.9 | 1.0 2.3 4.7 12.0 | 0.8 2.0 3.0 8.4 | 1.2 0.9 | 0.7 | | 10-14 | 1.8 4.9 7.2 15.8 | 1.5 3.7 6.9 12.1 | 1.1 3.0 5.0 9.9 | 1.6 1.4 | 1.0 | | 15-19 | 2.3 7.6 10.8 25.3 | 2.2 6.4 11.2 27.8 | 1.6 4.9 7.8 18.9 | 2.2 2.0 | 1.5 | | 20-24 | 3.2 13.1 14.7 37.6 | 3.1 11.3 15.4 37.0 | 2.2 8.6 10.7 26.4 | 3.2 3.0 | 2.2 | | 25-29 | 4.1 18.7 18.6 44.8 | 3.7 14.9 14.8 46.8 | 2.8 11.9 11.8 32.4 | 4.2 3.7 | 2.8 | | 30-34 | 4.7 21.3 21.7 55.3 | 4.2 16.7 18.6 56.8 | 3.1 13.5 14.2 39.7 | 4.8 4.1 | 3.1 | | 35-39 | 5.1 26.0 25.7 74.7 | 4.4 19.2 23.4 64.9 | 3.4 16.0 17.3 49.3 | 5.5 4.5 | 3.5 | | 40-44 | 6.0 34.9 32.3 99.4 | 4.9 24.1 27.2 78.4 | 3.8 21.0 21.0 62.8 | 6.8 5.2 | 4.2 | | 45-49 | 7.0 47.7 40.1 144.5 | 5.7 32.4 34.3 116.1 | 4.5 28.6 26.3 92.0 | 8.6 6.5 | 5.3 | | 50-54 | 8.9 63.9 56.7 201.7 | 7.3 46.5 47.0 171.9 | 5.7 39.2 36.6 131.9 | 11.2 8.7 | 7.0 | | 55-59 | 10.8 78.2 75.1 263.6 | 9.1 59.4 61.1 244.6 | 7.0 48.8 48.1 179.2 | 13.8 11.0 | 8.7 | | 60-64 | 12.7 89.8 95.5 319.8 | 10.6 73.1 72.7 312.3 | 8.2 57.6 59.6 223.3 | 16.0 13.2 | 10.3 | | 65-69 | 13.9 91.0 119.6 375.2 | 11.2 80.8 92.1 377.0 | 8.9 60.7 75.0 265.8 | 17.1 14.5 | 11.2 | | 70-74 | 16.0 110.6 149.5 368.7 | 11.6 95.3 117.0 405.4 | 9.8 72.7 94.4 274.1 | 20.2 16.3 | 12.9 | | 75-79 | 19.2 122.6 202.3 455.4 | 12.1 98.5 158.8 414.3 | 11.2 78.2 127.8 306.3 | 23.6 17.3 | 14.5 | | 80-84 | 24.4 157.9 257.8 462.8 | 12.6 105.2 208.8 407.9 | 13.5 94.1 164.4 307.2 | 30.1 18.8 | 17.5 | | 85 plus | 24.3 136.3 244.2 412.6 | 8.9 77.4 160.7 247.0 | 12.7 77.3 144.1 240.2 | 28.1 13.7 | 15.3 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1.6 10.4 12.6 34.6 | 1.2 8.0 10.0 32.5 | 1.0 6.4 7.9 23.7 | 1.8 1.4 | 1.1 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995 U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.12 December 31 Point Prevalence Counts Of Reported ESRD Therapy By Age, By Sex, By Race By Primary Disease Causing ESRD 1993-1996 Diabetes ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 13 * * * 20| 16 * * * 25| 29 * * * 45| | 5- 9 | * 0 0 0 *| * * * 0 *| * * * 0 12| | 10-14 | * 0 0 0 *| * * 0 0 *| * * 0 0 *| | 15-19 | 16 11 * 0 30| 21 13 * 0 36| 37 24 * 0 66| | 20-24 | 200 102 * * 307| 244 187 * 10 449| 444 289 * 14 756| | 25-29 | 1650 486 25 10 2171| 1775 702 27 32 2536| 3425 1188 52 42 4707| | 30-34 | 5799 1084 92 61 7036| 4776 1147 94 84 6101| 10575 2231 186 145 13137| | 35-39 | 9076 1584 181 130 10971| 6308 1588 153 133 8182| 15384 3172 334 263 19153| | 40-44 | 10448 2656 259 260 13623| 6966 2229 160 193 9548| 17414 4885 419 453 23171| | 45-49 | 11175 4032 376 489 16072| 7388 3895 296 375 11954| 18563 7927 672 864 28026| | 50-54 | 10473 5017 580 577 16647| 7432 5899 345 551 14227| 17905 10916 925 1128 30874| | 55-59 | 10421 6146 637 643 17847| 9030 7986 553 733 18302| 19451 14132 1190 1376 36149| | 60-64 | 11172 6238 734 594 18738| 11444 9695 673 854 22666| 22616 15933 1407 1448 41404| | 65-69 | 11935 5396 727 468 18526| 13969 10608 922 819 26318| 25904 16004 1649 1287 44844| | 70-74 | 9736 3763 621 227 14347| 12218 8406 861 597 22082| 21954 12169 1482 824 36429| | 75-79 | 5491 1962 354 110 7917| 6726 4554 516 278 12074| 12217 6516 870 388 19991| | 80-84 | 2112 723 166 46 3047| 2769 1769 213 105 4856| 4881 2492 379 151 7903| | 85 plus | 562 224 67 * 858| 801 513 74 30 1418| 1363 737 141 35 2276| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 100284 39427 4824 3627 148162| 91888 59202 4899 4796 160785|192172 98629 9723 8423 308947| ----------------------------------------------------------------------------------------------------------------------- Hypertension ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 11 13 0 * 25| * * 0 * 18| 20 21 0 * 43| | 5- 9 | 17 * 0 0 22| 22 * 0 0 23| 39 * 0 0 45| | 10-14 | 24 * 0 * 34| 33 11 0 * 48| 57 18 0 * 82| | 15-19 | 66 109 * * 184| 108 63 * * 180| 174 172 * 11 364| | 20-24 | 387 828 46 11 1272| 325 332 19 23 699| 712 1160 65 34 1971| | 25-29 | 999 1917 89 28 3033| 584 822 40 24 1470| 1583 2739 129 52 4503| | 30-34 | 1797 3250 148 48 5243| 986 1622 117 14 2739| 2783 4872 265 62 7982| | 35-39 | 2355 5739 240 71 8405| 1279 2704 170 46 4199| 3634 8443 410 117 12604| | 40-44 | 3081 8379 288 101 11849| 1594 3781 237 64 5676| 4675 12160 525 165 17525| | 45-49 | 3793 9392 284 157 13626| 2121 4597 275 63 7056| 5914 13989 559 220 20682| | 50-54 | 4270 8587 321 115 13293| 2630 4861 298 81 7870| 6900 13448 619 196 21163| | 55-59 | 4926 7750 364 88 13128| 3054 5541 274 83 8952| 7980 13291 638 171 22080| | 60-64 | 6546 7146 349 113 14154| 4133 6426 312 80 10951| 10679 13572 661 193 25105| | 65-69 | 9834 6505 411 108 16858| 6348 7339 441 94 14222| 16182 13844 852 202 31080| | 70-74 | 12137 5195 503 106 17941| 7979 7191 426 108 15704| 20116 12386 929 214 33645| | 75-79 | 11315 3403 412 51 15181| 7795 5167 418 86 13466| 19110 8570 830 137 28647| | 80-84 | 7286 1879 290 29 9484| 5481 3053 271 59 8864| 12767 4932 561 88 18348| | 85 plus | 3128 826 134 22 4110| 2773 1622 110 36 4541| 5901 2448 244 58 8651| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 71972 70930 3880 1060 147842| 47254 55141 3414 869 106678|119226 126071 7294 1929 254520| ----------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31, 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table B.12 (Continued) December 31 Point Prevalence Counts Of Reported ESRD Therapy By Age, By Sex, By Race By Primary Disease Causing ESRD 1993-1996 Glomeruloneph. ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 66 * * 0 75| 73 * * * 86| 139 15 * * 161| | 5- 9 | 250 56 * 11 322| 214 45 13 * 277| 464 101 18 16 599| | 10-14 | 523 164 27 * 721| 482 121 45 * 657| 1005 285 72 16 1378| | 15-19 | 1035 634 67 30 1766| 1010 418 60 54 1542| 2045 1052 127 84 3308| | 20-24 | 2344 1501 203 57 4105| 1938 1066 199 51 3254| 4282 2567 402 108 7359| | 25-29 | 4263 2263 362 86 6974| 3194 1509 234 70 5007| 7457 3772 596 156 11981| | 30-34 | 6596 2654 493 101 9844| 4181 1981 324 96 6582| 10777 4635 817 197 16426| | 35-39 | 8187 3407 584 166 12344| 4705 2182 563 123 7573| 12892 5589 1147 289 19917| | 40-44 | 8746 3922 710 165 13543| 4976 2273 592 92 7933| 13722 6195 1302 257 21476| | 45-49 | 8473 3427 614 144 12658| 4867 2048 540 109 7564| 13340 5475 1154 253 20222| | 50-54 | 7162 2243 512 140 10057| 4091 1489 381 117 6078| 11253 3732 893 257 16135| | 55-59 | 6252 1716 430 127 8525| 3546 1317 313 71 5247| 9798 3033 743 198 13772| | 60-64 | 5969 1369 278 72 7688| 3457 1189 222 57 4925| 9426 2558 500 129 12613| | 65-69 | 5947 1050 251 70 7318| 3730 1029 239 49 5047| 9677 2079 490 119 12365| | 70-74 | 5357 777 283 39 6456| 3439 872 186 37 4534| 8796 1649 469 76 10990| | 75-79 | 3721 409 154 45 4329| 2550 550 162 27 3289| 6271 959 316 72 7618| | 80-84 | 2038 191 83 17 2329| 1441 244 75 14 1774| 3479 435 158 31 4103| | 85 plus | 733 66 37 * 839| 602 164 19 * 787| 1335 230 56 * 1626| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 77662 25856 5095 1280 109893| 48496 18505 4170 985 72156|126158 44361 9265 2265 182049| ----------------------------------------------------------------------------------------------------------------------- Cystic Kidney ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 61 * 0 * 66| 53 * * * 64| 114 * * * 130| | 5- 9 | 102 24 * * 131| 74 10 * * 89| 176 34 * * 220| | 10-14 | 125 10 * * 143| 107 24 10 0 141| 232 34 11 * 284| | 15-19 | 140 15 * * 164| 153 26 15 0 194| 293 41 21 * 358| | 20-24 | 211 21 11 * 246| 229 24 * 0 260| 440 45 18 * 506| | 25-29 | 273 28 12 * 316| 253 20 * * 284| 526 48 18 * 600| | 30-34 | 381 67 * * 459| 399 77 12 10 498| 780 144 15 18 957| | 35-39 | 913 115 19 11 1058| 666 142 12 11 831| 1579 257 31 22 1889| | 40-44 | 1915 219 57 24 2215| 1120 282 50 14 1466| 3035 501 107 38 3681| | 45-49 | 3229 383 89 29 3730| 2367 397 63 18 2845| 5596 780 152 47 6575| | 50-54 | 3694 437 98 41 4270| 3041 544 61 29 3675| 6735 981 159 70 7945| | 55-59 | 3311 393 95 11 3810| 3137 415 72 38 3662| 6448 808 167 49 7472| | 60-64 | 2728 333 64 22 3147| 2963 439 60 20 3482| 5691 772 124 42 6629| | 65-69 | 2146 256 53 * 2464| 2659 270 62 15 3006| 4805 526 115 24 5470| | 70-74 | 1482 143 47 * 1677| 1798 211 37 * 2050| 3280 354 84 * 3727| | 75-79 | 639 89 28 * 762| 866 111 23 * 1008| 1505 200 51 14 1770| | 80-84 | 322 33 * 0 360| 321 28 * 0 358| 643 61 14 0 718| | 85 plus | 104 20 * 0 126| 71 28 * 0 101| 175 48 * 0 227| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 21776 2590 592 186 25144| 20277 3051 510 176 24014| 42053 5641 1102 362 49158| ----------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31, 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table B.12 (Continued) December 31 Point Prevalence Counts Of Reported ESRD Therapy By Age, By Sex, By Race By Primary Disease Causing ESRD 1993-1996 Other Urologic ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 95 33 * 0 132| 14 0 0 0 14| 109 33 * 0 146| | 5- 9 | 139 38 * 0 182| 24 * 0 0 27| 163 41 * 0 209| | 10-14 | 250 59 13 * 330| 99 * * * 112| 349 67 15 11 442| | 15-19 | 379 100 14 0 493| 213 18 * 0 233| 592 118 16 0 726| | 20-24 | 483 89 19 * 599| 308 30 * * 350| 791 119 24 15 949| | 25-29 | 703 111 14 15 843| 373 50 14 10 447| 1076 161 28 25 1290| | 30-34 | 636 123 29 10 798| 446 33 10 12 501| 1082 156 39 22 1299| | 35-39 | 611 110 15 10 746| 536 58 20 10 624| 1147 168 35 20 1370| | 40-44 | 645 106 16 * 772| 426 83 18 * 528| 1071 189 34 * 1300| | 45-49 | 499 100 24 * 624| 458 73 19 * 554| 957 173 43 * 1178| | 50-54 | 426 80 13 * 526| 409 87 30 * 529| 835 167 43 10 1055| | 55-59 | 448 101 27 * 585| 406 76 28 0 510| 854 177 55 * 1095| | 60-64 | 568 130 28 11 737| 418 95 19 * 534| 986 225 47 13 1271| | 65-69 | 688 194 26 * 915| 473 103 24 * 606| 1161 297 50 13 1521| | 70-74 | 999 173 24 * 1203| 465 102 31 * 601| 1464 275 55 10 1804| | 75-79 | 939 125 32 10 1106| 419 62 16 * 502| 1358 187 48 15 1608| | 80-84 | 660 120 26 * 811| 192 33 13 0 238| 852 153 39 * 1049| | 85 plus | 268 61 * * 343| 69 18 * 0 90| 337 79 * * 433| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 9436 1853 335 121 11745| 5748 932 254 66 7000| 15184 2785 589 187 18745| ----------------------------------------------------------------------------------------------------------------------- Other Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 400 86 * * 496| 153 41 * * 199| 553 127 10 * 695| | 5- 9 | 679 171 * * 866| 274 73 15 * 368| 953 244 24 13 1234| | 10-14 | 1079 272 47 11 1409| 600 106 17 * 730| 1679 378 64 18 2139| | 15-19 | 1550 339 68 33 1990| 1057 315 60 30 1462| 2607 654 128 63 3452| | 20-24 | 2147 503 87 46 2783| 1780 720 122 26 2648| 3927 1223 209 72 5431| | 25-29 | 2955 897 115 45 4012| 2558 1246 143 38 3985| 5513 2143 258 83 7997| | 30-34 | 3800 1285 101 52 5238| 3594 1879 183 63 5719| 7394 3164 284 115 10957| | 35-39 | 3799 1622 103 78 5602| 3825 2181 227 49 6282| 7624 3803 330 127 11884| | 40-44 | 3549 1694 135 48 5426| 3560 1868 228 62 5718| 7109 3562 363 110 11144| | 45-49 | 3045 1328 97 47 4517| 3476 1424 236 55 5191| 6521 2752 333 102 9708| | 50-54 | 2628 921 68 45 3662| 3075 1107 207 39 4428| 5703 2028 275 84 8090| | 55-59 | 2462 790 92 57 3401| 2804 861 116 33 3814| 5266 1651 208 90 7215| | 60-64 | 2658 707 82 31 3478| 2864 892 122 35 3913| 5522 1599 204 66 7391| | 65-69 | 3168 618 84 35 3905| 3309 775 120 44 4248| 6477 1393 204 79 8153| | 70-74 | 3132 588 71 20 3811| 2939 606 103 35 3683| 6071 1194 174 55 7494| | 75-79 | 2584 375 64 19 3042| 2149 385 71 20 2625| 4733 760 135 39 5667| | 80-84 | 1569 213 28 * 1819| 1178 233 31 10 1452| 2747 446 59 19 3271| | 85 plus | 645 112 21 10 788| 494 132 * * 637| 1139 244 30 12 1425| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 41849 12521 1278 597 56245| 39689 14844 2014 555 57102| 81538 27365 3292 1152 113347| ----------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31, 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table B.12 (Continued) December 31 Point Prevalence Counts Of Reported ESRD Therapy By Age, By Sex, By Race By Primary Disease Causing ESRD 1993-1996 Unknown Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 51 10 0 0 61| 19 * 0 0 20| 70 11 0 0 81| | 5- 9 | 106 17 * 0 126| 89 * * * 96| 195 21 * * 222| | 10-14 | 196 57 * * 256| 162 32 * * 200| 358 89 * * 456| | 15-19 | 349 129 12 12 502| 267 80 20 * 373| 616 209 32 18 875| | 20-24 | 730 254 26 22 1032| 584 198 36 16 834| 1314 452 62 38 1866| | 25-29 | 1195 474 67 16 1752| 825 271 48 16 1160| 2020 745 115 32 2912| | 30-34 | 1576 548 111 45 2280| 1319 358 81 33 1791| 2895 906 192 78 4071| | 35-39 | 1870 866 143 28 2907| 1330 440 54 16 1840| 3200 1306 197 44 4747| | 40-44 | 1938 906 102 37 2983| 1364 539 120 21 2044| 3302 1445 222 58 5027| | 45-49 | 1657 978 111 34 2780| 1242 528 123 18 1911| 2899 1506 234 52 4691| | 50-54 | 1504 633 112 34 2283| 1159 486 102 27 1774| 2663 1119 214 61 4057| | 55-59 | 1380 614 97 21 2112| 1095 557 69 33 1754| 2475 1171 166 54 3866| | 60-64 | 1542 581 99 25 2247| 1176 653 97 26 1952| 2718 1234 196 51 4199| | 65-69 | 1707 603 91 41 2442| 1521 657 96 26 2300| 3228 1260 187 67 4742| | 70-74 | 1925 442 65 18 2450| 1370 554 107 31 2062| 3295 996 172 49 4512| | 75-79 | 1655 283 68 21 2027| 1181 379 74 10 1644| 2836 662 142 31 3671| | 80-84 | 1000 151 40 * 1199| 847 220 49 12 1128| 1847 371 89 20 2327| | 85 plus | 459 70 15 * 548| 426 163 14 * 608| 885 233 29 * 1156| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 20840 7616 1163 368 29987| 15976 6120 1096 299 23491| 36816 13736 2259 667 53478| ----------------------------------------------------------------------------------------------------------------------- Missing Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 34 * * 0 44| 28 10 0 0 38| 62 18 * 0 82| | 5- 9 | 51 15 * 0 67| 32 * 0 0 36| 83 19 * 0 103| | 10-14 | 69 30 0 * 101| 72 17 0 0 89| 141 47 0 * 190| | 15-19 | 134 54 0 * 189| 99 52 * 0 156| 233 106 * * 345| | 20-24 | 220 99 * 0 326| 156 55 * 0 216| 376 154 12 0 542| | 25-29 | 373 122 * * 503| 301 106 * * 415| 674 228 * 11 918| | 30-34 | 546 176 13 * 742| 582 128 10 * 727| 1128 304 23 14 1469| | 35-39 | 904 287 14 * 1209| 784 159 13 * 963| 1688 446 27 11 2172| | 40-44 | 1115 312 32 12 1471| 774 226 14 * 1015| 1889 538 46 13 2486| | 45-49 | 1068 385 11 10 1474| 729 200 * * 940| 1797 585 19 13 2414| | 50-54 | 831 350 * * 1192| 626 200 13 0 839| 1457 550 21 * 2031| | 55-59 | 752 321 * 14 1094| 545 322 12 12 891| 1297 643 19 26 1985| | 60-64 | 592 385 11 * 994| 560 382 15 10 967| 1152 767 26 16 1961| | 65-69 | 682 360 15 0 1057| 657 486 14 17 1174| 1339 846 29 17 2231| | 70-74 | 466 221 13 * 705| 444 270 10 * 726| 910 491 23 * 1431| | 75-79 | 321 113 * 0 440| 334 195 * * 542| 655 308 14 * 982| | 80-84 | 176 55 0 0 231| 175 92 12 * 282| 351 147 12 * 513| | 85 plus | 81 26 * 0 109| 94 34 * 0 132| 175 60 * 0 241| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 8415 3319 146 68 11948| 6992 2938 144 74 10148| 15407 6257 290 142 22096| ----------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31, 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table B.13 December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD Specific Rates By Sex, By Race, By Age And Rates Adjusted For Age, Race, And Sex 1993-1996 Diabetes ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | * * * * | * * * * | * * * * | * * | * | | 5- 9 | * 0 0 0 | * * * 0 | * * * 0 | * * | * | | 10-14 | * 0 0 0 | * * 0 0 | * * 0 0 | * * | * | | 15-19 | * 19 * 0 | * 23 * 0 | * 21 * 0 | * * | * | | 20-24 | 67 196 * * | 87 350 * 274 | 77 275 * 190 | 81 120 | 101 | | 25-29 | 526 972 153 261 | 581 1287 154 900 | 554 1134 154 588 | 566 657 | 613 | | 30-34 | 1610 2048 548 1625 | 1348 1917 522 2254 | 1477 1982 536 1949 | 1627 1399 | 1511 | | 35-39 | 2438 3035 1125 3694 | 1719 2688 879 3685 | 2070 2852 997 3686 | 2475 1826 | 2144 | | 40-44 | 3077 5972 1820 8561 | 2055 4346 994 6006 | 2550 5123 1391 7217 | 3436 2334 | 2872 | | 45-49 | 3762 11818 3254 19997 | 2455 9590 2232 14545 | 3080 10614 2709 17077 | 4877 3428 | 4135 | | 50-54 | 4574 20305 6894 31954 | 3134 19431 3718 28175 | 3824 19794 5237 29925 | 6851 5407 | 6114 | | 55-59 | 5603 30806 9845 46576 | 4573 31289 7652 48165 | 5064 30954 8648 47184 | 9255 8405 | 8823 | | 60-64 | 6723 36645 14733 54834 | 6259 42926 10686 69137 | 6495 39826 12588 62035 | 11200 11585 | 11407 | | 65-69 | 7473 34427 18384 54670 | 7377 50413 16749 80166 | 7431 42521 17476 67519 | 11660 13767 | 12764 | | 70-74 | 7109 33352 19781 34411 | 6925 50418 20891 72280 | 7013 42018 20230 53529 | 11095 13465 | 12335 | | 75-79 | 5523 25081 18237 26339 | 4688 35816 19730 46565 | 5073 30429 18720 36394 | 8576 9473 | 9055 | | 80-84 | 3597 16736 14392 17643 | 2674 21080 14774 26049 | 3106 18930 14331 21898 | 5726 5615 | 5679 | | 85 plus | 1517 6941 8490 * | 839 6539 6629 7270 | 1162 6676 7305 4797 | 2435 1801 | 2111 | | All Age | 2339 6280 2647 8106 | 2070 8516 2534 10560 | 2202 7455 2589 9342 | 2881 2993 | 2938 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 2346 8944 4004 12389 | 1910 10388 3433 15287 | 2118 9769 3707 14055 | 3068 2806 | 2941 | ------------------------------------------------------------------------------------------------------------------------- Hypertension ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | * 21 0 * | * * 0 * | * 17 0 * | * * | * | | 5- 9 | * * 0 0 | * * 0 0 | * * 0 0 | * * | * | | 10-14 | * * 0 * | 11 19 0 * | * 15 0 * | * 12 | 10 | | 15-19 | 22 190 * * | 38 113 * * | 30 151 * 132 | 44 48 | 46 | | 20-24 | 130 1593 291 283 | 116 622 123 631 | 123 1098 205 463 | 322 184 | 250 | | 25-29 | 318 3836 547 731 | 191 1507 229 675 | 253 2648 384 700 | 774 362 | 560 | | 30-34 | 498 6141 881 1279 | 278 2710 650 375 | 386 4390 764 817 | 1231 599 | 902 | | 35-39 | 632 10996 1492 2017 | 348 4577 977 1274 | 487 7709 1228 1631 | 1981 911 | 1423 | | 40-44 | 907 18841 2023 3325 | 470 7372 1472 1991 | 682 12966 1740 2622 | 3226 1386 | 2266 | | 45-49 | 1277 27530 2458 6420 | 704 11319 2074 2443 | 983 19191 2245 4358 | 4659 2103 | 3325 | | 50-54 | 1865 34753 3815 6368 | 1109 16012 3211 4141 | 1476 25133 3487 5186 | 6108 3085 | 4531 | | 55-59 | 2648 38846 5626 6374 | 1546 21709 3791 5453 | 2083 30058 4659 5879 | 7342 4199 | 5707 | | 60-64 | 3939 41979 7005 10431 | 2260 28452 4954 6476 | 3083 35061 5919 8402 | 8902 5695 | 7242 | | 65-69 | 6157 41503 10393 12616 | 3352 34877 8011 9200 | 4725 38098 9164 10846 | 10819 7545 | 9140 | | 70-74 | 8862 46044 16022 16068 | 4522 43131 10336 13075 | 6644 44538 13049 14498 | 13865 9668 | 11724 | | 75-79 | 11381 43503 21226 12211 | 5433 40637 15983 14405 | 8329 41983 18488 13194 | 15761 10321 | 12988 | | 80-84 | 12412 43497 25144 11123 | 5293 36382 18796 14637 | 8759 39837 21682 12822 | 16748 9764 | 13180 | | 85 plus | 8444 25598 16981 10920 | 2905 20675 9855 8724 | 5596 22988 13290 9859 | 10903 5424 | 8105 | | All Age | 1678 11299 2129 2369 | 1064 7932 1766 1913 | 1366 9530 1942 2139 | 2875 1986 | 2421 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1792 15522 3408 3714 | 918 9644 2438 2765 | 1290 12471 2853 3222 | 3238 1799 | 2429 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31, 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.13 (Continued) December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD Specific Rates By Sex, By Race, By Age And Rates Adjusted For Age, Race, And Sex 1993-1996 Glomeruloneph. ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 20 * * 0 | 24 * * * | 22 12 * * | 19 22 | 21 | | 5- 9 | 80 91 * 240 | 72 75 92 * | 76 83 63 174 | 81 73 | 77 | | 10-14 | 170 280 179 * | 165 213 310 * | 167 245 245 172 | 184 176 | 180 | | 15-19 | 345 1105 484 724 | 360 751 449 1343 | 352 923 466 1042 | 448 421 | 434 | | 20-24 | 789 2888 1286 1471 | 693 1999 1292 1400 | 740 2436 1289 1434 | 1078 886 | 979 | | 25-29 | 1359 4529 2225 2246 | 1046 2767 1340 1969 | 1199 3631 1770 2092 | 1798 1282 | 1531 | | 30-34 | 1831 5015 2937 2691 | 1180 3310 1802 2576 | 1500 4145 2354 2636 | 2281 1484 | 1872 | | 35-39 | 2199 6528 3630 4717 | 1282 3693 3238 3408 | 1730 5075 3423 4038 | 2817 1673 | 2229 | | 40-44 | 2575 8819 4989 5433 | 1468 4432 3677 2863 | 2008 6567 4300 4107 | 3471 1930 | 2678 | | 45-49 | 2852 10045 5314 5888 | 1617 5042 4073 4227 | 2216 7448 4655 5019 | 3861 2153 | 2981 | | 50-54 | 3128 9078 6086 7753 | 1725 4904 4106 5982 | 2407 6926 5063 6845 | 4017 2244 | 3106 | | 55-59 | 3361 8601 6646 9199 | 1796 5160 4331 4665 | 2558 6831 5441 6875 | 4184 2333 | 3235 | | 60-64 | 3592 8042 5580 6646 | 1890 5264 3525 4614 | 2724 6619 4511 5585 | 4252 2398 | 3303 | | 65-69 | 3723 6699 6347 8177 | 1969 4890 4341 4796 | 2828 5771 5306 6448 | 4231 2448 | 3320 | | 70-74 | 3911 6886 9014 5912 | 1949 5230 4513 4479 | 2908 6036 6693 5168 | 4485 2477 | 3459 | | 75-79 | 3742 5228 7933 10775 | 1777 4325 6194 4522 | 2733 4758 6971 7510 | 4129 2278 | 3185 | | 80-84 | 3471 4421 7196 6520 | 1391 2907 5202 3473 | 2404 3645 6104 5024 | 3742 1735 | 2718 | | 85 plus | 1978 2045 4688 * | 630 2090 1702 * | 1283 2060 3094 * | 2065 849 | 1446 | | All Age | 1811 4118 2796 2860 | 1092 2662 2157 2168 | 1446 3353 2467 2512 | 2137 1343 | 1731 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1820 4815 3323 3737 | 1050 2899 2338 2557 | 1409 3832 2793 3103 | 2223 1308 | 1735 | ------------------------------------------------------------------------------------------------------------------------- Cystic Kidney ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 19 * 0 * | 17 * * * | 18 * * * | 16 17 | 17 | | 5- 9 | 32 39 * * | 25 16 * * | 28 27 * * | 33 23 | 28 | | 10-14 | 40 17 * * | 36 42 68 0 | 38 29 38 * | 37 38 | 37 | | 15-19 | 46 26 * * | 54 46 112 0 | 50 36 77 * | 44 55 | 49 | | 20-24 | 71 40 69 * | 81 45 * 0 | 76 42 57 * | 67 75 | 71 | | 25-29 | 87 56 73 * | 82 36 * * | 84 46 52 * | 82 75 | 79 | | 30-34 | 105 126 * * | 112 128 66 268 | 109 127 42 241 | 106 114 | 110 | | 35-39 | 245 220 118 312 | 181 240 69 304 | 212 230 92 308 | 237 185 | 211 | | 40-44 | 563 492 400 790 | 330 549 310 435 | 444 519 356 608 | 550 357 | 452 | | 45-49 | 1087 1122 770 1185 | 786 977 475 698 | 932 1045 613 940 | 1077 798 | 935 | | 50-54 | 1613 1768 1164 2270 | 1282 1791 657 1482 | 1442 1777 909 1859 | 1619 1324 | 1469 | | 55-59 | 1780 1969 1468 796 | 1588 1625 996 2496 | 1681 1792 1221 1659 | 1782 1578 | 1677 | | 60-64 | 1641 1956 1284 2030 | 1620 1943 952 1619 | 1631 1949 1110 1817 | 1671 1637 | 1654 | | 65-69 | 1343 1633 1340 * | 1404 1283 1126 1468 | 1375 1454 1232 1265 | 1378 1379 | 1378 | | 70-74 | 1082 1267 1497 * | 1019 1265 897 * | 1049 1264 1198 * | 1116 1041 | 1078 | | 75-79 | 642 1137 1442 * | 603 872 879 * | 620 1002 1138 1406 | 738 651 | 693 | | 80-84 | 548 763 * 0 | 310 333 * 0 | 427 543 497 0 | 567 319 | 440 | | 85 plus | 280 619 * 0 | 74 356 * 0 | 175 483 * 0 | 318 113 | 213 | | All Age | 507 412 324 415 | 456 438 263 387 | 482 426 293 401 | 489 447 | 467 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 506 560 427 550 | 429 513 310 496 | 465 533 364 523 | 507 433 | 468 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.13 (Continued) December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD Specific Rates By Sex, By Race, By Age And Rates Adjusted For Age, Race, And Sex 1993-1996 Other Urologic ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 30 53 * 0 | * 0 0 0 | 17 26 * 0 | 32 * | 17 | | 5- 9 | 44 62 * 0 | * * 0 0 | 26 33 * 0 | 46 * | 26 | | 10-14 | 81 100 86 * | 33 * * * | 57 56 49 115 | 84 30 | 57 | | 15-19 | 126 174 101 0 | 76 32 * 0 | 100 101 57 0 | 130 67 | 98 | | 20-24 | 162 171 120 * | 110 56 * * | 136 112 75 199 | 162 101 | 131 | | 25-29 | 224 222 86 391 | 122 91 80 281 | 172 155 84 336 | 220 118 | 168 | | 30-34 | 176 232 172 266 | 125 55 55 322 | 151 141 111 294 | 184 116 | 149 | | 35-39 | 164 210 93 284 | 146 98 115 277 | 154 153 104 278 | 168 139 | 153 | | 40-44 | 189 238 112 * | 125 161 111 * | 156 198 110 * | 192 128 | 159 | | 45-49 | 168 293 207 * | 152 179 143 * | 158 232 173 * | 182 154 | 168 | | 50-54 | 186 323 154 * | 172 286 323 * | 178 303 239 265 | 203 191 | 197 | | 55-59 | 240 506 417 * | 205 297 387 0 | 222 398 397 * | 283 221 | 251 | | 60-64 | 341 763 562 1015 | 228 420 301 * | 284 588 422 580 | 408 255 | 329 | | 65-69 | 430 1237 657 * | 249 489 436 * | 338 854 538 705 | 543 289 | 413 | | 70-74 | 729 1533 764 * | 263 611 752 * | 491 1062 763 700 | 834 326 | 574 | | 75-79 | 944 1597 1648 2394 | 292 487 611 * | 609 1033 1139 1599 | 1063 333 | 689 | | 80-84 | 1124 2777 2254 * | 185 393 901 0 | 641 1559 1554 * | 1373 235 | 789 | | 85 plus | 723 1890 * * | 72 229 * 0 | 388 1037 * * | 893 96 | 485 | | All Age | 220 295 183 270 | 129 134 131 145 | 174 210 156 207 | 228 130 | 178 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 228 410 264 416 | 123 156 163 169 | 169 266 206 269 | 246 126 | 178 | ------------------------------------------------------------------------------------------------------------------------- Other Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 126 140 * * | 50 68 * * | 87 104 29 * | 124 52 | 87 | | 5- 9 | 218 279 * * | 92 122 106 * | 154 199 84 143 | 219 97 | 157 | | 10-14 | 350 464 312 232 | 206 186 117 * | 276 322 213 190 | 362 199 | 279 | | 15-19 | 516 591 491 796 | 377 566 449 746 | 445 577 468 772 | 526 406 | 465 | | 20-24 | 723 967 551 1187 | 637 1350 792 714 | 680 1165 674 949 | 752 734 | 744 | | 25-29 | 942 1795 706 1175 | 838 2284 819 1069 | 889 2046 763 1120 | 1043 1022 | 1033 | | 30-34 | 1055 2428 601 1385 | 1014 3140 1018 1690 | 1035 2792 813 1543 | 1216 1289 | 1254 | | 35-39 | 1020 3107 640 2216 | 1042 3691 1305 1357 | 1030 3399 979 1767 | 1278 1386 | 1335 | | 40-44 | 1045 3809 948 1580 | 1050 3642 1416 1929 | 1046 3700 1186 1744 | 1389 1394 | 1391 | | 45-49 | 1025 3892 839 1922 | 1155 3506 1780 2133 | 1087 3654 1315 1996 | 1377 1474 | 1426 | | 50-54 | 1147 3727 808 2492 | 1296 3646 2230 1994 | 1220 3678 1520 2232 | 1467 1629 | 1550 | | 55-59 | 1323 3959 1421 4128 | 1420 3373 1605 2168 | 1370 3650 1514 3112 | 1681 1674 | 1676 | | 60-64 | 1599 4153 1645 2861 | 1566 3949 1937 2833 | 1584 4047 1786 2840 | 1934 1891 | 1912 | | 65-69 | 1983 3942 2124 4088 | 1747 3683 2180 4306 | 1864 3810 2143 4190 | 2253 2030 | 2139 | | 70-74 | 2286 5211 2261 3031 | 1665 3634 2499 4237 | 1969 4404 2388 3627 | 2659 1966 | 2304 | | 75-79 | 2599 4793 3297 4549 | 1497 3027 2714 3350 | 2029 3882 3002 3904 | 2907 1747 | 2313 | | 80-84 | 2672 4930 2427 * | 1137 2776 2150 2480 | 1880 3828 2246 2973 | 2943 1387 | 2147 | | 85 plus | 1741 3470 2661 4963 | 517 1682 * * | 1110 2548 1690 2623 | 2008 672 | 1325 | | All Age | 976 1994 701 1334 | 894 2135 1041 1222 | 934 2068 876 1277 | 1093 1063 | 1078 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 990 2414 866 1716 | 859 2300 1125 1484 | 914 2338 991 1583 | 1143 1034 | 1078 | (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.13 (Continued) December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD Specific Rates By Sex, By Race, By Age And Rates Adjusted For Age, Race, And Sex 1993-1996 Unknown Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 16 16 0 0 | * * 0 0 | 11 * 0 0 | 15 * | 10 | | 5- 9 | 34 27 * 0 | 30 * * * | 32 17 * * | 32 26 | 29 | | 10-14 | 63 97 * * | 55 56 * * | 59 76 * * | 65 54 | 60 | | 15-19 | 116 225 86 289 | 95 143 149 * | 105 182 120 219 | 130 103 | 116 | | 20-24 | 245 488 164 567 | 209 371 233 439 | 226 428 200 501 | 276 232 | 253 | | 25-29 | 380 948 411 418 | 270 496 275 450 | 324 718 342 432 | 454 300 | 375 | | 30-34 | 437 1035 661 1199 | 372 598 450 885 | 404 812 554 1038 | 527 408 | 465 | | 35-39 | 502 1659 889 795 | 362 744 310 443 | 430 1191 591 613 | 664 409 | 532 | | 40-44 | 570 2037 716 1218 | 402 1050 745 653 | 484 1532 730 925 | 766 498 | 628 | | 45-49 | 557 2866 960 1390 | 412 1300 927 698 | 482 2059 947 1030 | 869 543 | 700 | | 50-54 | 656 2561 1331 1882 | 488 1600 1099 1380 | 570 2067 1200 1622 | 930 658 | 789 | | 55-59 | 742 3077 1499 1521 | 554 2182 954 2168 | 645 2622 1218 1851 | 1070 787 | 924 | | 60-64 | 928 3413 1987 2307 | 643 2891 1540 2104 | 782 3146 1752 2207 | 1291 971 | 1127 | | 65-69 | 1068 3847 2301 4789 | 803 3122 1744 2544 | 933 3479 2012 3650 | 1496 1145 | 1316 | | 70-74 | 1405 3917 2070 2728 | 776 3322 2596 3753 | 1084 3611 2342 3240 | 1757 1188 | 1467 | | 75-79 | 1664 3617 3503 5028 | 823 2980 2829 1675 | 1233 3290 3097 3337 | 2001 1173 | 1579 | | 80-84 | 1703 3495 3468 * | 818 2621 3398 2977 | 1249 3047 3423 3047 | 2002 1156 | 1570 | | 85 plus | 1239 2169 1900 * | 446 2077 1254 * | 830 2119 1545 * | 1382 683 | 1026 | | All Age | 486 1213 638 822 | 360 880 566 658 | 421 1038 601 739 | 583 437 | 508 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 498 1557 836 1177 | 338 1021 687 859 | 409 1279 756 1005 | 622 417 | 509 | ------------------------------------------------------------------------------------------------------------------------- Missing Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 10 * * 0 | * 16 0 0 | 10 15 * 0 | 11 * | 10 | | 5- 9 | 16 24 * 0 | 10 * 0 0 | 13 15 * 0 | 16 * | 13 | | 10-14 | 22 51 0 * | 24 29 0 0 | 23 40 0 * | 25 24 | 24 | | 15-19 | 44 94 0 * | 35 93 * 0 | 39 93 * * | 48 42 | 45 | | 20-24 | 74 190 * 0 | 55 103 * 0 | 64 146 38 0 | 87 60 | 73 | | 25-29 | 118 244 * * | 98 194 * * | 108 218 * 152 | 131 108 | 119 | | 30-34 | 151 332 77 * | 164 213 55 * | 158 272 66 187 | 172 166 | 169 | | 35-39 | 242 549 87 * | 213 269 74 * | 227 406 80 153 | 274 215 | 244 | | 40-44 | 328 701 224 395 | 228 440 86 * | 277 569 153 210 | 372 248 | 308 | | 45-49 | 359 1128 95 408 | 242 492 * * | 299 804 74 267 | 447 266 | 354 | | 50-54 | 362 1416 * * | 264 658 140 0 | 312 1032 114 * | 484 307 | 393 | | 55-59 | 404 1608 * 1014 | 276 1261 166 788 | 339 1441 140 911 | 552 403 | 475 | | 60-64 | 356 2261 220 * | 306 1691 238 809 | 330 1971 224 685 | 592 482 | 535 | | 65-69 | 427 2296 379 0 | 346 2309 254 1664 | 385 2315 317 857 | 659 602 | 630 | | 70-74 | 340 1958 414 * | 251 1619 242 * | 295 1792 333 * | 552 425 | 487 | | 75-79 | 322 1444 * 0 | 232 1533 * * | 280 1510 320 * | 469 408 | 438 | | 80-84 | 299 1273 0 0 | 169 1096 832 * | 237 1189 453 * | 416 319 | 366 | | 85 plus | 218 805 * 0 | 98 433 * 0 | 161 623 * 0 | 299 153 | 224 | | All Age | 196 528 80 151 | 157 422 74 162 | 176 472 77 157 | 232 188 | 210 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 197 700 101 194 | 151 498 97 228 | 172 595 101 217 | 244 182 | 211 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.14 Standard Errors For Adjusted December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD By Sex, By Race, By Age Adjusted For Age, Race, And Sex 1993-1996 Diabetes ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 1.1 * * * | 1.3 * * * | 0.8 * * * | 1.0 1.2 | 0.8 | | 5- 9 | * 0.0 0.0 0.0 | * * * 0.0 | * * * 0.0 | * * | 0.4 | | 10-14 | * 0.0 0.0 0.0 | * * 0.0 0.0 | * * 0.0 0.0 | * * | * | | 15-19 | 1.3 5.7 * 0.0 | 1.6 6.4 * 0.0 | 1.0 4.3 * 0.0 | 1.3 1.6 | 1.0 | | 20-24 | 4.7 19.4 * * | 5.5 25.6 * 86.8 | 3.6 16.2 * 51.0 | 4.6 5.7 | 3.7 | | 25-29 | 12.9 44.1 30.7 82.6 | 13.8 48.5 29.7 159.1 | 9.4 32.9 21.4 90.9 | 12.1 13.0 | 8.9 | | 30-34 | 21.1 62.2 57.1 208.1 | 19.5 56.6 53.9 245.9 | 14.3 41.9 39.3 161.9 | 19.4 17.9 | 13.1 | | 35-39 | 25.5 76.2 83.6 324.0 | 21.6 67.4 71.1 319.5 | 16.7 50.6 54.6 227.3 | 23.6 20.2 | 15.5 | | 40-44 | 30.1 115.8 113.0 530.9 | 24.6 92.0 78.5 432.3 | 19.3 73.4 68.1 339.3 | 29.5 23.9 | 18.8 | | 45-49 | 35.5 186.1 167.8 904.2 | 28.5 153.6 129.7 751.1 | 22.6 119.8 104.9 581.6 | 38.8 31.4 | 24.8 | | 50-54 | 44.6 286.6 286.2 1330.2 | 36.3 252.9 200.1 1200.3 | 28.5 190.1 172.7 891.8 | 53.8 45.5 | 35.1 | | 55-59 | 54.8 392.9 390.1 1836.8 | 48.1 350.1 325.4 1779.0 | 36.3 261.8 251.2 1273.0 | 70.3 62.4 | 46.8 | | 60-64 | 63.6 463.9 543.8 2249.9 | 58.5 435.9 411.9 2365.8 | 43.2 317.7 337.4 1632.1 | 83.4 77.5 | 56.8 | | 65-69 | 68.4 468.6 681.8 2527.1 | 62.4 489.4 551.6 2801.2 | 46.2 338.6 435.2 1886.2 | 88.1 86.3 | 61.7 | | 70-74 | 72.0 543.7 793.8 2283.9 | 62.6 549.9 711.9 2958.2 | 47.5 386.3 529.8 1871.7 | 97.2 93.8 | 67.5 | | 75-79 | 74.5 566.2 969.3 2511.3 | 57.1 530.7 868.6 2792.8 | 46.5 385.9 642.0 1870.7 | 102.4 90.6 | 68.2 | | 80-84 | 78.2 622.4 1117.0 2601.3 | 50.8 501.2 1012.2 2542.1 | 45.9 397.2 741.2 1819.0 | 111.2 86.8 | 70.0 | | 85 plus | 64.0 463.8 1037.2 * | 29.6 288.7 770.7 1327.3 | 34.5 268.3 626.4 843.2 | 87.0 52.4 | 50.0 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 7.4 46.1 60.8 213.5 | 6.3 42.9 50.8 224.9 | 4.8 31.4 39.3 157.4 | 8.0 7.0 | 5.2 | ------------------------------------------------------------------------------------------------------------------------- Hypertension ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 1.0 5.8 0.0 * | * * 0.0 * | 0.7 3.8 0.0 * | 1.1 1.0 | 0.7 | | 5- 9 | 1.3 * 0.0 0.0 | 1.5 * 0.0 0.0 | 1.0 * 0.0 0.0 | 1.1 1.3 | 0.8 | | 10-14 | 1.5 * 0.0 * | 1.9 5.8 0.0 * | 1.2 3.7 0.0 * | 1.4 1.8 | 1.1 | | 15-19 | 2.7 18.2 * * | 3.7 14.2 * * | 2.3 11.5 * 39.9 | 3.2 3.6 | 2.4 | | 20-24 | 6.6 55.3 42.9 85.6 | 6.4 34.1 28.3 131.7 | 4.6 32.2 25.5 79.5 | 9.0 7.0 | 5.6 | | 25-29 | 10.0 87.6 57.9 138.2 | 7.9 52.5 36.2 137.8 | 6.3 50.6 33.8 97.2 | 14.0 9.5 | 8.3 | | 30-34 | 11.7 107.7 72.4 184.6 | 8.8 67.3 60.1 100.4 | 7.3 62.9 46.9 103.8 | 17.0 11.4 | 10.1 | | 35-39 | 13.0 145.1 96.3 239.4 | 9.7 88.0 74.9 187.9 | 8.0 83.9 60.7 150.8 | 21.6 14.0 | 12.6 | | 40-44 | 16.3 205.8 119.2 330.9 | 11.7 119.8 95.6 248.9 | 9.9 117.8 76.1 204.2 | 29.7 18.4 | 17.1 | | 45-49 | 20.7 284.0 145.8 512.3 | 15.3 166.9 125.0 307.8 | 12.8 163.0 95.3 294.2 | 40.3 25.1 | 23.2 | | 50-54 | 28.5 375.0 212.9 593.8 | 21.6 229.6 186.0 460.2 | 17.7 217.4 140.5 370.7 | 53.5 34.9 | 31.4 | | 55-59 | 37.7 441.2 294.8 679.5 | 27.9 291.6 229.0 598.6 | 23.3 262.0 184.9 449.9 | 64.9 44.5 | 38.7 | | 60-64 | 48.6 496.5 374.9 981.3 | 35.1 354.9 280.4 724.1 | 29.8 303.0 231.4 605.6 | 76.1 54.7 | 46.3 | | 65-69 | 62.0 514.5 512.6 1214.0 | 42.0 407.1 381.5 949.0 | 37.2 326.3 317.5 765.0 | 85.4 64.1 | 52.9 | | 70-74 | 80.4 638.8 714.4 1560.7 | 50.6 508.6 500.7 1258.2 | 47.0 406.2 431.6 995.5 | 108.5 79.4 | 66.6 | | 75-79 | 106.9 745.7 1045.7 1709.9 | 61.5 565.3 781.7 1553.3 | 60.9 464.8 648.4 1142.3 | 135.2 93.0 | 81.2 | | 80-84 | 145.4 1003.4 1476.5 2065.4 | 71.5 658.4 1141.8 1905.6 | 79.8 594.6 922.1 1393.7 | 183.3 111.1 | 105.6 | | 85 plus | 150.9 890.6 1466.9 2328.2 | 55.1 513.3 939.6 1454.0 | 78.8 506.7 865.9 1385.1 | 177.2 86.8 | 96.9 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 6.7 60.3 59.1 121.7 | 4.2 41.3 44.0 96.4 | 3.7 35.6 35.6 76.5 | 8.4 5.5 | 4.8 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.14 (Continued) Standard Errors For Adjusted December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD By Sex, By Race, By Age Adjusted For Age, Race, And Sex 1993-1996 Glomeruloneph. ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 2.5 * * 0.0 | 2.8 * * * | 1.9 3.2 * * | 2.2 2.4 | 1.6 | | 5- 9 | 5.0 12.2 * 72.4 | 4.9 11.2 25.5 * | 3.5 8.3 14.9 43.6 | 4.5 4.4 | 3.1 | | 10-14 | 7.4 21.8 34.5 * | 7.5 19.3 46.2 * | 5.2 14.5 28.9 43.1 | 6.8 6.9 | 4.8 | | 15-19 | 10.7 43.9 59.1 132.2 | 11.3 36.7 57.9 182.8 | 7.8 28.5 41.4 113.9 | 10.7 10.8 | 7.6 | | 20-24 | 16.3 74.5 90.2 194.8 | 15.7 61.2 91.6 196.1 | 11.3 48.1 64.3 138.2 | 16.8 15.6 | 11.4 | | 25-29 | 20.8 95.2 116.9 242.2 | 18.5 71.2 87.6 235.4 | 13.9 59.1 72.5 167.9 | 21.5 18.1 | 14.0 | | 30-34 | 22.5 97.3 132.3 267.8 | 18.2 74.3 100.1 262.9 | 14.4 60.9 82.3 187.9 | 23.0 18.3 | 14.6 | | 35-39 | 24.3 111.8 150.2 366.1 | 18.6 79.0 136.4 307.2 | 15.2 67.9 101.1 237.6 | 25.3 19.2 | 15.8 | | 40-44 | 27.5 140.8 187.2 422.9 | 20.8 92.9 151.1 298.5 | 17.1 83.6 119.4 256.3 | 29.9 21.6 | 18.3 | | 45-49 | 30.9 171.5 214.4 490.7 | 23.1 111.4 175.2 404.9 | 19.2 101.1 137.6 315.9 | 34.6 24.8 | 21.1 | | 50-54 | 36.9 191.6 268.9 655.2 | 26.9 127.1 210.3 553.1 | 22.7 113.7 169.9 427.4 | 40.5 28.8 | 24.6 | | 55-59 | 42.5 207.6 320.5 816.3 | 30.1 142.1 244.8 553.6 | 25.8 124.6 200.1 489.0 | 45.8 32.3 | 27.8 | | 60-64 | 46.4 217.3 334.6 783.3 | 32.1 152.6 236.5 611.2 | 28.0 131.7 202.9 492.4 | 49.2 34.3 | 29.7 | | 65-69 | 48.2 206.7 400.6 977.3 | 32.2 152.4 280.8 685.1 | 28.8 127.5 242.4 592.5 | 50.6 34.9 | 30.4 | | 70-74 | 53.4 247.0 535.8 946.6 | 33.2 177.1 330.9 736.4 | 31.1 150.8 311.2 595.7 | 58.0 37.9 | 34.3 | | 75-79 | 61.3 258.5 639.3 1606.2 | 35.1 184.4 486.6 870.3 | 34.9 157.4 396.4 895.4 | 65.9 41.8 | 38.6 | | 80-84 | 76.9 319.9 789.9 1581.4 | 36.6 186.1 600.6 928.2 | 41.9 182.9 488.8 920.6 | 81.6 44.7 | 45.9 | | 85 plus | 73.0 251.7 770.8 * | 25.7 163.2 390.5 * | 37.8 148.2 419.4 * | 73.7 32.8 | 39.7 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 6.5 30.8 49.7 111.3 | 4.7 21.5 37.6 83.9 | 3.9 18.5 30.4 68.0 | 6.7 4.8 | 4.0 | ------------------------------------------------------------------------------------------------------------------------- Cystic Kidney ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 2.4 * 0.0 * | 2.4 * * * | 1.7 * * * | 2.0 2.1 | 1.4 | | 5- 9 | 3.2 8.0 * * | 2.9 5.3 * * | 2.1 4.7 * * | 2.9 2.5 | 1.9 | | 10-14 | 3.6 5.4 * * | 3.5 8.6 21.7 0.0 | 2.5 5.1 11.7 * | 3.1 3.2 | 2.2 | | 15-19 | 3.9 6.7 * * | 4.4 9.1 28.9 0.0 | 2.9 5.7 16.8 * | 3.4 3.9 | 2.6 | | 20-24 | 4.8 8.8 21.0 * | 5.4 9.1 * 0.0 | 3.6 6.3 13.4 * | 4.2 4.6 | 3.1 | | 25-29 | 5.2 10.5 21.2 * | 5.2 8.2 * * | 3.7 6.6 12.4 * | 4.6 4.5 | 3.2 | | 30-34 | 5.4 15.4 * * | 5.6 14.6 19.2 84.8 | 3.9 10.6 11.0 57.0 | 4.9 5.1 | 3.5 | | 35-39 | 8.1 20.5 27.1 94.2 | 7.0 20.1 19.9 91.8 | 5.3 14.3 16.6 65.7 | 7.3 6.4 | 4.8 | | 40-44 | 12.8 33.2 53.0 161.3 | 9.8 32.7 43.9 116.4 | 8.0 23.2 34.5 98.8 | 11.7 9.3 | 7.4 | | 45-49 | 19.1 57.3 81.6 220.2 | 16.1 49.0 59.8 164.5 | 12.4 37.6 49.9 137.3 | 17.7 15.0 | 11.5 | | 50-54 | 26.5 84.6 117.6 354.6 | 23.2 76.8 84.1 275.3 | 17.5 56.9 72.2 222.5 | 24.9 21.9 | 16.5 | | 55-59 | 30.9 99.3 150.6 240.2 | 28.3 79.8 117.4 405.0 | 20.9 63.3 94.7 237.2 | 29.1 26.1 | 19.5 | | 60-64 | 31.4 107.1 160.5 432.9 | 29.7 92.7 122.9 362.0 | 21.6 70.6 100.2 280.7 | 30.1 27.8 | 20.4 | | 65-69 | 29.0 102.0 184.1 * | 27.2 78.0 143.0 379.0 | 19.8 63.9 116.2 258.9 | 28.2 25.3 | 18.9 | | 70-74 | 28.1 105.9 218.3 * | 24.0 87.1 147.5 * | 18.4 68.2 131.7 * | 28.1 23.4 | 18.2 | | 75-79 | 25.4 120.6 272.6 * | 20.5 82.8 183.3 * | 16.2 72.6 161.0 381.6 | 28.2 21.3 | 17.5 | | 80-84 | 30.5 132.9 * 0.0 | 17.3 63.0 * 0.0 | 17.4 72.4 134.1 0.0 | 31.1 17.7 | 17.7 | | 85 plus | 27.5 138.5 * 0.0 | 8.8 67.4 * 0.0 | 14.1 75.7 * 0.0 | 29.3 12.3 | 15.5 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 3.4 11.2 18.4 42.3 | 3.0 9.3 14.1 38.1 | 2.2 7.1 11.4 28.3 | 3.2 2.8 | 2.1 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.14 (Continued) Standard Errors For Adjusted December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD By Sex, By Race, By Age Adjusted For Age, Race, And Sex 1993-1996 Other Urologic ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 3.0 9.3 * 0.0 | 1.2 0.0 0.0 0.0 | 1.6 4.6 * 0.0 | 2.8 1.0 | 1.4 | | 5- 9 | 3.7 10.0 * 0.0 | 1.6 * 0.0 0.0 | 2.0 5.1 * 0.0 | 3.4 1.4 | 1.8 | | 10-14 | 5.1 13.1 23.9 * | 3.4 * * * | 3.0 6.9 12.8 34.9 | 4.6 2.9 | 2.7 | | 15-19 | 6.4 17.4 27.0 0.0 | 5.2 7.6 * 0.0 | 4.1 9.3 14.3 0.0 | 5.8 4.4 | 3.6 | | 20-24 | 7.4 18.1 27.6 * | 6.2 10.2 * * | 4.8 10.3 15.4 51.5 | 6.6 5.4 | 4.2 | | 25-29 | 8.4 21.0 22.9 101.1 | 6.3 12.9 21.4 88.9 | 5.2 12.2 15.9 67.4 | 7.5 5.6 | 4.6 | | 30-34 | 7.0 20.9 32.0 84.2 | 5.9 9.6 17.5 92.9 | 4.6 11.3 17.9 62.8 | 6.5 5.2 | 4.1 | | 35-39 | 6.6 20.0 24.0 89.8 | 6.3 12.8 25.7 87.6 | 4.5 11.8 17.6 62.3 | 6.1 5.5 | 4.1 | | 40-44 | 7.4 23.1 28.1 * | 6.0 17.7 26.3 * | 4.7 14.4 19.0 * | 6.9 5.5 | 4.4 | | 45-49 | 7.5 29.3 42.4 * | 7.1 21.0 32.8 * | 5.1 17.7 26.6 * | 7.3 6.5 | 4.9 | | 50-54 | 9.0 36.1 42.8 * | 8.5 30.7 59.0 * | 6.1 23.5 36.5 84.0 | 8.9 8.3 | 6.1 | | 55-59 | 11.3 50.3 80.3 * | 10.2 34.1 73.2 0.0 | 7.6 30.0 53.7 * | 11.8 9.8 | 7.6 | | 60-64 | 14.3 66.9 106.2 306.1 | 11.1 43.1 69.2 * | 9.0 39.4 61.8 161.0 | 15.3 11.0 | 9.3 | | 65-69 | 16.4 88.8 128.9 * | 11.4 48.2 88.9 * | 9.9 49.9 77.0 196.0 | 18.4 11.9 | 10.8 | | 70-74 | 23.0 116.5 156.0 * | 12.2 60.5 135.0 * | 12.8 64.8 103.8 222.2 | 25.0 13.7 | 14.0 | | 75-79 | 30.8 142.9 291.4 757.1 | 14.2 61.9 152.9 * | 16.6 76.9 165.6 418.0 | 33.6 15.6 | 18.2 | | 80-84 | 43.7 253.5 442.1 * | 13.3 68.4 250.0 0.0 | 22.3 128.8 250.4 * | 51.2 16.7 | 26.2 | | 85 plus | 44.1 242.0 * * | 8.7 54.0 * 0.0 | 21.9 121.2 * * | 50.1 11.0 | 24.9 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 2.3 10.2 15.8 42.4 | 1.6 5.1 10.7 21.8 | 1.3 5.2 9.0 21.0 | 2.2 1.5 | 1.3 | ------------------------------------------------------------------------------------------------------------------------- Other Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 6.3 15.1 * * | 4.1 10.7 * * | 3.7 9.2 9.4 * | 5.6 3.7 | 3.3 | | 5- 9 | 8.3 21.3 * * | 5.6 14.3 27.4 * | 5.0 12.7 17.2 39.9 | 7.5 5.1 | 4.5 | | 10-14 | 10.6 28.1 45.5 70.2 | 8.4 18.1 28.4 * | 6.7 16.5 26.6 44.8 | 9.6 7.4 | 6.0 | | 15-19 | 13.1 32.1 59.5 138.6 | 11.6 31.8 57.9 136.3 | 8.7 22.5 41.4 97.4 | 11.8 10.7 | 7.9 | | 20-24 | 15.6 43.1 59.1 175.0 | 15.1 50.3 71.7 140.0 | 10.8 33.3 46.7 111.9 | 14.3 14.3 | 10.1 | | 25-29 | 17.3 59.9 65.9 175.2 | 16.5 64.7 68.5 173.4 | 11.9 44.2 47.6 123.2 | 16.4 16.2 | 11.5 | | 30-34 | 17.1 67.7 59.8 192.1 | 16.9 72.4 75.2 213.0 | 12.0 49.6 48.2 144.0 | 16.8 17.0 | 11.9 | | 35-39 | 16.5 77.1 63.0 250.9 | 16.8 79.0 86.6 193.9 | 11.8 55.1 53.9 156.9 | 17.1 17.5 | 12.2 | | 40-44 | 17.5 92.5 81.6 228.1 | 17.6 84.2 93.8 245.0 | 12.4 62.1 62.3 166.4 | 18.9 18.4 | 13.2 | | 45-49 | 18.5 106.8 85.2 280.3 | 19.5 92.9 115.8 287.6 | 13.4 70.0 72.3 197.9 | 20.7 20.5 | 14.5 | | 50-54 | 22.3 122.8 98.0 371.4 | 23.3 109.5 155.0 319.3 | 16.1 81.9 91.9 243.8 | 24.5 24.5 | 17.3 | | 55-59 | 26.6 140.8 148.2 546.8 | 26.8 114.9 149.0 377.4 | 18.8 90.3 105.2 328.3 | 29.2 27.2 | 19.9 | | 60-64 | 31.0 156.1 181.7 513.9 | 29.2 132.2 175.3 478.9 | 21.3 101.9 125.7 350.0 | 33.3 30.4 | 22.5 | | 65-69 | 35.2 158.6 231.7 691.1 | 30.3 132.3 199.0 649.2 | 23.2 102.9 151.7 472.5 | 36.8 31.5 | 24.1 | | 70-74 | 40.8 214.9 268.4 677.9 | 30.7 147.6 246.2 716.2 | 25.4 129.3 182.4 491.0 | 44.8 33.3 | 27.7 | | 75-79 | 51.1 247.5 412.1 1043.7 | 32.3 154.3 322.2 749.0 | 29.8 144.1 261.2 632.7 | 55.2 35.6 | 32.5 | | 80-84 | 67.4 337.8 458.7 * | 33.1 181.9 386.1 784.5 | 36.9 189.5 294.7 697.9 | 72.7 38.8 | 40.5 | | 85 plus | 68.5 327.9 580.7 1569.7 | 23.2 146.4 * * | 35.4 176.5 312.1 778.3 | 74.2 28.5 | 38.9 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 4.8 22.5 26.4 76.4 | 4.3 19.0 26.0 65.2 | 3.2 14.4 18.3 49.1 | 4.8 4.3 | 3.2 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.14 (Continued) Standard Errors For Adjusted December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD By Sex, By Race, By Age Adjusted For Age, Race, And Sex 1993-1996 Unknown Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 2.2 5.1 0.0 0.0 | 1.4 * 0.0 0.0 | 1.3 2.6 0.0 0.0 | 1.9 1.2 | 1.1 | | 5- 9 | 3.3 6.7 * 0.0 | 3.1 * * * | 2.3 3.7 * * | 2.9 2.7 | 1.9 | | 10-14 | 4.5 12.9 * * | 4.3 9.9 * * | 3.1 8.1 * * | 4.1 3.8 | 2.8 | | 15-19 | 6.2 19.8 25.0 83.6 | 5.8 16.0 33.4 * | 4.2 12.6 21.3 51.8 | 5.8 5.4 | 3.9 | | 20-24 | 9.1 30.6 32.3 121.0 | 8.6 26.3 38.9 109.8 | 6.2 20.1 25.4 81.5 | 8.6 8.0 | 5.9 | | 25-29 | 11.0 43.5 50.3 104.5 | 9.4 30.1 39.6 112.5 | 7.2 26.3 31.9 76.6 | 10.8 8.8 | 6.9 | | 30-34 | 11.0 44.2 62.7 178.7 | 10.2 31.6 50.0 154.1 | 7.5 27.0 40.0 117.6 | 11.0 9.6 | 7.3 | | 35-39 | 11.6 56.3 74.3 150.3 | 9.9 35.5 42.2 110.8 | 7.6 33.0 42.1 92.4 | 12.3 9.5 | 7.7 | | 40-44 | 12.9 67.6 70.9 200.2 | 10.8 45.2 68.0 142.6 | 8.4 40.3 49.1 121.5 | 14.0 11.0 | 8.8 | | 45-49 | 13.7 91.6 91.1 238.4 | 11.7 56.5 83.6 164.5 | 8.9 53.3 62.2 143.0 | 16.6 12.4 | 10.3 | | 50-54 | 16.9 101.8 125.7 322.9 | 14.3 72.6 108.8 265.7 | 11.0 62.0 82.3 207.9 | 19.7 15.6 | 12.5 | | 55-59 | 19.9 124.2 152.2 331.9 | 16.7 92.4 114.9 377.4 | 12.9 77.0 94.8 252.1 | 23.6 18.8 | 15.0 | | 60-64 | 23.6 141.5 199.7 461.5 | 18.7 113.1 156.3 412.8 | 15.0 90.2 125.8 309.5 | 27.7 22.1 | 17.6 | | 65-69 | 25.8 156.6 241.2 747.9 | 20.5 121.8 177.9 499.1 | 16.4 98.7 148.8 446.9 | 31.1 24.2 | 19.5 | | 70-74 | 32.0 186.3 256.8 643.1 | 20.9 141.1 250.9 674.1 | 18.9 116.1 180.1 464.7 | 37.0 27.1 | 22.7 | | 75-79 | 40.9 215.0 424.8 1097.2 | 23.9 153.1 328.9 529.6 | 23.4 131.0 262.6 606.2 | 46.9 30.4 | 27.6 | | 80-84 | 53.8 284.4 548.3 * | 28.1 176.7 485.5 859.4 | 29.9 165.8 365.6 697.7 | 61.3 37.4 | 35.4 | | 85 plus | 57.8 259.2 490.8 * | 21.6 162.7 335.2 * | 30.2 151.5 293.6 * | 61.2 29.8 | 33.5 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 3.4 18.5 26.5 66.6 | 2.6 13.1 21.8 51.4 | 2.1 11.1 16.9 40.9 | 3.6 2.7 | 2.2 | ------------------------------------------------------------------------------------------------------------------------- Missing Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 1.8 * * 0.0 | 1.7 5.3 0.0 0.0 | 1.2 3.5 * 0.0 | 1.6 1.6 | 1.1 | | 5- 9 | 2.2 6.3 * 0.0 | 1.9 * 0.0 0.0 | 1.4 3.5 * 0.0 | 2.0 1.6 | 1.3 | | 10-14 | 2.7 9.3 0.0 * | 2.9 7.2 0.0 0.0 | 1.9 5.8 0.0 * | 2.5 2.5 | 1.8 | | 15-19 | 3.8 12.8 0.0 * | 3.5 12.9 * 0.0 | 2.6 9.0 * * | 3.5 3.4 | 2.4 | | 20-24 | 4.9 19.1 * 0.0 | 4.4 13.9 * 0.0 | 3.3 11.7 11.0 0.0 | 4.8 4.1 | 3.1 | | 25-29 | 6.1 22.1 * * | 5.6 18.8 * * | 4.1 14.4 * 45.9 | 5.8 5.3 | 3.9 | | 30-34 | 6.4 25.0 21.4 * | 6.8 18.9 17.5 * | 4.7 15.6 13.7 50.0 | 6.3 6.1 | 4.4 | | 35-39 | 8.0 32.4 23.2 * | 7.6 21.3 20.7 * | 5.5 19.2 15.4 46.3 | 7.9 6.9 | 5.2 | | 40-44 | 9.8 39.7 39.7 114.0 | 8.2 29.3 23.2 * | 6.3 24.6 22.7 58.4 | 9.7 7.7 | 6.2 | | 45-49 | 11.0 57.5 28.7 129.3 | 8.9 34.8 * * | 7.0 33.4 17.0 74.2 | 11.7 8.7 | 7.2 | | 50-54 | 12.5 75.7 * * | 10.5 46.5 38.8 0.0 | 8.1 44.1 25.1 * | 14.2 10.6 | 8.8 | | 55-59 | 14.7 89.8 * 271.0 | 11.8 70.3 47.9 227.6 | 9.4 57.1 32.3 178.7 | 16.9 13.5 | 10.7 | | 60-64 | 14.6 115.2 66.5 * | 12.9 86.5 61.4 256.0 | 9.7 71.7 44.0 171.6 | 19.1 15.6 | 12.2 | | 65-69 | 16.3 121.0 97.9 0.0 | 13.5 104.7 67.9 403.5 | 10.5 80.2 59.6 208.0 | 20.7 17.8 | 13.6 | | 70-74 | 15.7 131.7 114.8 * | 11.9 98.5 76.7 * | 9.8 82.1 69.8 * | 21.8 16.2 | 13.4 | | 75-79 | 18.0 135.8 * 0.0 | 12.7 109.8 * * | 11.1 88.2 86.6 * | 23.6 18.3 | 14.8 | | 80-84 | 22.6 171.6 0.0 0.0 | 12.7 114.3 240.2 * | 13.1 102.8 131.2 * | 29.0 20.6 | 17.6 | | 85 plus | 24.2 158.0 * 0.0 | 10.1 74.3 * 0.0 | 13.3 87.2 * 0.0 | 29.8 14.7 | 16.3 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 2.1 12.6 9.0 24.5 | 1.8 9.2 8.7 27.3 | 1.3 7.6 6.5 19.0 | 2.2 1.8 | 1.4 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.15 December 31 Point Prevalence Counts of Reported ESRD Therapy By State After Dropping Territories and Unknown States Year 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 State Alabama 1,740 2,010 3,213 3,477 3,799 4,169 4,492 4,897 5,349 5,861 Alaska 108 128 150 165 195 229 248 416 673 560 Arizona 1,711 1,876 2,142 2,394 2,684 3,036 3,301 3,645 4,069 4,351 Arkansas 1,095 1,226 1,310 1,451 1,627 1,760 1,943 2,212 2,487 2,655 California 13,909 15,071 16,859 18,693 20,657 22,316 23,763 26,190 28,379 30,190 Colorado 1,192 1,249 1,439 1,597 1,760 1,984 2,152 2,370 2,513 2,695 Connecticut 1,696 1,775 1,947 2,137 2,363 2,563 2,717 2,915 3,161 3,382 Delaware 380 436 466 526 585 673 720 765 849 920 District of Columbia 799 811 916 1,005 1,111 1,218 1,336 1,353 1,425 1,524 Florida 6,627 7,362 8,204 9,211 10,241 11,357 12,288 13,274 14,551 15,851 Georgia 3,728 4,159 4,699 5,225 5,895 6,607 7,232 8,079 8,922 9,653 Hawaii 667 745 827 889 978 1,054 1,182 1,332 1,428 1,489 Idaho 335 363 414 481 519 549 606 673 722 780 Illinois 6,279 6,705 7,263 8,051 8,935 9,785 10,677 11,623 12,610 13,395 Indiana 2,610 2,901 3,194 3,510 3,814 4,235 4,611 4,872 5,367 5,786 Iowa 1,224 1,311 1,456 1,612 1,737 1,942 2,075 2,232 2,324 2,462 Kansas 1,004 1,089 1,230 1,402 1,538 1,666 1,750 1,919 2,058 2,174 Kentucky 1,600 1,771 1,937 2,125 2,383 2,670 2,889 2,952 3,321 3,525 Louisiana 2,638 2,954 3,274 3,610 3,981 4,387 4,752 5,183 5,700 6,112 Maine 355 478 518 574 608 667 729 812 906 963 Maryland 2,516 2,812 3,165 3,613 4,065 4,489 4,886 5,266 5,857 6,560 Massachusetts 2,741 3,005 3,258 3,527 3,852 4,241 4,608 4,933 5,314 5,584 Michigan 4,463 4,909 5,567 6,184 6,756 7,535 8,246 9,082 9,878 10,779 Minnesota 1,943 2,094 2,296 2,559 2,781 3,012 3,222 3,507 3,803 4,064 Mississippi 1,638 1,837 2,041 2,239 2,469 2,729 3,008 3,376 3,671 3,966 Missouri 2,533 2,784 3,156 3,502 3,841 4,169 4,559 4,923 5,391 5,788 Montana 308 321 382 425 468 504 541 587 661 684 Nebraska 627 684 779 862 939 1,078 1,144 1,262 1,390 1,437 Nevada 473 517 578 631 725 809 882 1,012 1,133 1,260 New Hampshire 369 409 479 522 569 598 629 683 734 757 New Jersey 4,485 4,756 5,185 5,751 6,377 6,948 7,379 8,078 8,673 9,214 New Mexico 676 802 890 998 1,136 1,250 1,335 1,468 1,668 1,822 New York 10,071 10,661 11,604 12,575 13,790 15,062 16,231 17,543 18,780 19,847 North Carolina 3,636 4,002 4,470 5,050 5,608 6,309 7,005 7,797 8,528 9,221 North Dakota 248 263 328 368 406 458 500 542 550 560 Ohio 5,269 5,870 6,544 7,198 7,812 8,541 9,183 9,858 10,906 11,782 Oklahoma 1,207 1,392 1,580 1,773 1,930 2,148 2,373 2,626 2,909 3,091 Oregon 1,126 1,252 1,413 1,562 1,756 1,862 2,003 2,196 2,337 2,498 Pennsylvania 6,672 7,262 7,982 8,829 9,595 10,370 10,956 11,919 13,073 13,795 Rhode Island 472 521 592 634 693 736 795 875 926 980 South Carolina 2,220 2,475 2,782 3,112 3,413 3,755 4,071 4,540 5,012 5,407 South Dakota 320 351 372 404 435 455 507 555 638 697 Tennessee 2,493 2,721 3,163 3,456 3,847 4,252 4,530 5,089 5,586 5,985 Texas 8,436 9,406 10,553 11,851 13,244 14,801 16,190 17,905 19,421 21,085 Utah 591 680 740 776 857 913 1,044 1,140 1,251 1,291 Vermont 196 220 236 249 288 304 318 344 398 424 Virginia 3,289 3,678 4,033 4,418 4,956 5,500 5,991 6,353 7,005 7,722 Washington 1,887 2,074 2,330 2,566 2,811 2,997 3,258 3,609 3,922 4,194 West Virginia 822 918 1,000 1,070 1,180 1,267 1,375 1,466 1,591 1,707 Wisconsin 2,184 2,482 2,799 3,032 3,377 3,755 4,024 4,405 4,759 5,073 Wyoming 129 162 180 189 205 204 224 245 274 294 -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- 123,737 135,740 151,935 168,060 185,591 203,918 220,480 240,898 262,853 281,896 Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31, 1995. Includes Medicare patients only. Rates per million based on the December 31, 1995 U.S. resident population by state for five-year age groups, sex, and White/non- White race groups. Table B.16 December 31 Point Prevalence Rates Per Million Population Of Reported ESRD Therapy By State Adjusted By Age, Race and Sex Year 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 State Alabama 459.13 528.80 833.81 887.77 954.10 1028.87 1090.81 1173.54 1265.11 1367.31 Alaska 231.48 259.14 309.35 322.94 367.69 415.85 439.23 716.11 1138.82 919.18 Arizona 526.01 560.66 624.48 680.23 744.81 814.19 851.29 888.70 941.64 969.13 Arkansas 478.50 535.16 568.19 623.44 691.65 735.64 800.58 898.55 997.53 1052.61 California 512.31 541.40 592.14 644.84 698.85 740.66 777.85 845.60 901.88 942.42 Colorado 396.93 412.01 466.31 501.28 537.80 582.35 609.03 648.77 668.89 698.14 Connecticut 564.58 579.11 629.90 683.16 750.11 806.70 848.78 904.77 973.41 1032.36 Delaware 659.16 729.26 767.46 843.30 918.29 1031.24 1069.25 1111.49 1196.38 1262.45 District of Columbia 1349.46 1380.90 1570.43 1755.74 1945.87 2151.66 2380.63 2454.92 2622.58 2835.06 Florida 574.09 621.15 673.41 736.23 797.93 863.64 912.45 959.85 1026.83 1092.58 Georgia 639.24 700.95 776.56 839.76 921.22 1000.61 1062.25 1151.93 1237.27 1299.98 Hawaii 699.77 759.00 815.11 852.72 897.94 944.17 1038.60 1153.85 1220.68 1255.50 Idaho 353.33 377.01 421.00 474.26 493.36 505.71 544.43 586.78 612.98 649.56 Illinois 577.69 610.62 655.04 718.77 788.05 853.27 920.88 994.51 1070.65 1128.04 Indiana 501.75 549.90 600.08 649.45 693.34 758.25 815.92 852.00 926.84 986.98 Iowa 471.78 500.60 549.86 600.29 637.05 706.21 745.38 794.81 820.65 862.00 Kansas 431.33 463.75 517.47 581.45 630.33 673.75 700.19 759.38 805.74 843.81 Kentucky 459.78 503.92 548.75 595.42 657.02 724.79 772.90 778.22 863.55 904.51 Louisiana 672.74 753.03 831.18 906.99 982.26 1062.59 1134.59 1220.46 1324.78 1402.85 Maine 314.29 411.08 442.53 486.36 511.31 556.30 602.88 665.70 735.05 773.07 Maryland 602.66 656.20 721.64 806.77 888.55 960.22 1021.26 1077.11 1173.52 1289.32 Massachusetts 490.25 534.09 574.59 619.25 670.10 731.52 784.81 830.12 882.76 914.96 Michigan 513.14 557.67 626.71 685.61 741.92 817.90 885.04 965.36 1038.50 1120.18 Minnesota 485.18 515.57 555.97 609.28 650.67 690.62 724.85 775.16 826.75 868.50 Mississippi 682.21 757.18 834.25 906.57 979.11 1067.03 1155.14 1275.79 1365.99 1454.84 Missouri 520.51 565.50 635.83 698.17 756.03 812.24 877.04 936.09 1013.46 1076.16 Montana 406.67 417.80 488.97 541.86 579.76 614.29 646.43 685.85 759.20 773.86 Nebraska 420.41 457.53 514.93 563.04 605.09 684.81 719.60 781.75 849.65 866.43 Nevada 504.38 513.86 540.57 554.99 588.77 623.45 642.26 691.80 730.48 769.23 New Hampshire 364.51 395.36 458.47 493.31 530.76 550.15 570.92 607.41 639.25 647.23 New Jersey 618.28 649.49 702.76 772.93 845.92 911.36 955.56 1032.90 1096.03 1150.72 New Mexico 498.24 580.01 629.25 686.92 754.96 804.59 836.25 894.94 991.82 1056.12 New York 598.10 627.11 676.98 726.66 791.31 857.23 915.90 981.88 1042.48 1091.58 North Carolina 592.30 639.91 701.59 777.16 846.65 934.47 1014.50 1104.23 1181.09 1248.93 North Dakota 405.33 426.94 547.20 609.22 674.31 740.64 809.34 866.07 861.98 868.82 Ohio 518.49 570.57 632.13 686.71 735.68 793.22 843.99 897.89 984.38 1052.70 Oklahoma 404.36 464.68 524.04 581.36 624.23 682.20 743.52 812.47 889.18 932.73 Oregon 426.74 466.91 513.37 555.41 607.05 628.78 658.99 707.87 738.72 773.09 Pennsylvania 586.37 634.38 694.72 760.80 819.52 878.23 922.11 998.37 1089.48 1144.43 Rhode Island 493.14 544.11 612.63 651.63 713.80 759.70 817.06 895.93 943.46 990.41 South Carolina 707.55 775.02 855.00 935.73 1005.00 1083.92 1154.54 1267.00 1375.02 1455.60 South Dakota 477.35 520.05 548.41 587.80 631.26 652.10 714.51 774.47 881.23 949.78 Tennessee 545.70 589.12 678.12 726.51 793.18 860.64 898.18 989.07 1064.06 1117.41 Texas 546.11 601.05 660.75 725.69 787.45 854.53 909.17 977.43 1031.97 1092.96 Utah 367.94 418.94 448.40 457.05 491.54 509.86 563.94 597.89 636.26 638.61 Vermont 387.71 422.66 456.52 464.09 527.13 545.73 563.72 602.09 684.88 717.92 Virginia 591.35 649.64 698.19 750.23 821.25 888.13 945.29 981.68 1062.62 1151.58 Washington 433.39 460.71 503.47 539.76 572.46 593.04 628.17 677.61 719.32 752.21 West Virginia 471.72 525.26 575.23 612.61 667.00 708.27 765.10 811.09 876.85 934.83 Wisconsin 489.53 547.07 607.89 647.76 709.11 774.20 815.58 878.27 933.65 979.60 Wyoming 286.94 370.05 420.79 431.90 461.30 454.04 488.55 524.46 575.36 609.32 Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31, 1995. Includes Medicare patients only. Rates per million based on the December 31, 1995 U.S. resident population by state for five-year age groups, sex, and White/non- White race groups. Table B.17 Standard Errors For Adjusted December 31 Point Prevalence Rates Per Million Population Of Reported ESRD Therapy By State Adjusted By Age, Race and Sex Year 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 State Alabama 11.18 11.95 14.86 15.18 15.56 15.98 16.28 16.75 17.26 17.81 Alaska 23.25 23.88 26.23 25.96 26.90 27.87 28.13 35.25 43.73 38.69 Arizona 12.90 13.10 13.62 14.01 14.45 14.82 14.84 14.72 14.74 14.67 Arkansas 14.68 15.48 15.86 16.50 17.24 17.58 18.18 19.09 19.97 20.39 California 4.44 4.49 4.62 4.76 4.89 4.98 5.05 5.23 5.35 5.42 Colorado 11.78 11.89 12.50 12.72 12.94 13.15 13.17 13.34 13.34 13.44 Connecticut 14.06 14.02 14.49 14.94 15.53 15.99 16.31 16.76 17.29 17.72 Delaware 34.43 35.45 35.98 37.14 38.22 39.89 39.89 40.15 40.97 41.50 District of Columbia 49.02 49.53 52.77 56.15 58.81 61.86 65.19 66.65 69.27 72.35 Florida 7.17 7.34 7.52 7.75 7.93 8.13 8.24 8.33 8.50 8.66 Georgia 10.69 11.05 11.48 11.73 12.07 12.34 12.50 12.80 13.07 13.19 Hawaii 28.27 28.91 29.38 29.54 29.18 29.33 30.31 31.63 32.27 32.48 Idaho 19.66 20.20 21.05 21.88 21.79 21.67 22.17 22.63 22.80 23.24 Illinois 7.40 7.54 7.76 8.07 8.37 8.65 8.92 9.22 9.52 9.73 Indiana 9.96 10.31 10.71 11.03 11.27 11.68 12.03 12.20 12.63 12.95 Iowa 13.77 14.05 14.59 15.10 15.38 16.08 16.39 16.83 17.01 17.35 Kansas 13.87 14.26 14.92 15.66 16.17 16.57 16.77 17.34 17.74 18.07 Kentucky 11.66 12.10 12.58 13.01 13.53 14.06 14.39 14.32 14.97 15.21 Louisiana 13.30 14.02 14.66 15.20 15.64 16.08 16.47 16.94 17.51 17.90 Maine 17.02 19.11 19.68 20.53 20.91 21.63 22.38 23.38 24.41 24.89 Maryland 12.23 12.55 12.98 13.54 14.02 14.37 14.62 14.83 15.30 15.88 Massachusetts 9.60 9.93 10.22 10.54 10.88 11.28 11.58 11.82 12.10 12.23 Michigan 7.81 8.07 8.49 8.79 9.08 9.45 9.76 10.13 10.43 10.77 Minnesota 11.27 11.49 11.79 12.19 12.44 12.64 12.80 13.10 13.40 13.61 Mississippi 17.19 17.94 18.71 19.36 19.83 20.50 21.09 21.94 22.49 23.04 Missouri 10.47 10.82 11.41 11.87 12.24 12.60 12.99 13.33 13.78 14.12 Montana 23.70 23.78 25.46 26.78 27.14 27.57 27.90 28.34 29.50 29.55 Nebraska 17.16 17.79 18.71 19.39 19.90 20.95 21.33 22.02 22.77 22.82 Nevada 23.81 23.08 22.92 22.49 22.08 22.04 21.69 21.76 21.69 21.65 New Hampshire 19.35 19.87 21.22 21.80 22.41 22.59 22.82 23.26 23.59 23.50 New Jersey 9.44 9.59 9.90 10.32 10.67 10.98 11.14 11.49 11.75 11.97 New Mexico 19.47 20.75 21.32 21.92 22.51 22.82 22.90 23.34 24.24 24.68 New York 6.07 6.16 6.35 6.53 6.77 7.01 7.20 7.41 7.60 7.74 North Carolina 9.96 10.22 10.58 11.00 11.35 11.79 12.12 12.49 12.76 12.97 North Dakota 26.46 26.79 30.61 32.16 34.20 34.75 36.50 37.42 36.72 36.65 Ohio 7.26 7.54 7.90 8.16 8.37 8.61 8.82 9.04 9.41 9.68 Oklahoma 11.79 12.58 13.29 13.90 14.27 14.75 15.27 15.85 16.47 16.75 Oregon 13.03 13.46 13.87 14.23 14.61 14.64 14.76 15.12 15.27 15.45 Pennsylvania 7.33 7.57 7.88 8.18 8.42 8.66 8.82 9.14 9.52 9.73 Rhode Island 23.33 24.37 25.64 26.26 27.37 28.17 29.06 30.30 30.97 31.59 South Carolina 15.25 15.77 16.37 16.90 17.28 17.73 18.10 18.78 19.37 19.72 South Dakota 27.20 28.24 28.82 29.65 30.56 30.74 31.79 32.88 34.83 35.88 Tennessee 11.12 11.45 12.19 12.46 12.86 13.24 13.36 13.86 14.21 14.41 Texas 6.08 6.31 6.52 6.73 6.89 7.05 7.15 7.30 7.40 7.51 Utah 15.39 16.28 16.66 16.55 16.90 16.94 17.49 17.71 17.98 17.76 Vermont 28.37 29.02 30.27 29.82 31.41 31.51 31.77 32.51 34.30 34.80 Virginia 10.50 10.87 11.12 11.38 11.73 12.01 12.22 12.31 12.67 13.07 Washington 10.22 10.31 10.59 10.78 10.88 10.88 11.03 11.29 11.48 11.60 West Virginia 16.80 17.61 18.43 18.95 19.57 19.98 20.68 21.19 21.97 22.60 Wisconsin 10.69 11.15 11.63 11.87 12.28 12.68 12.88 13.23 13.52 13.73 Wyoming 25.95 29.80 32.20 31.96 32.60 32.03 32.80 33.58 34.76 35.49 Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31, 1995. Includes Medicare patients only. Rates per million based on the December 31, 1995 U.S. resident population by state for five-year age groups, sex, and White/non- White race groups. Table B.18 December 31 Point Prevalence Counts of Reported ESRD Therapy By Network Before Dropping Territories and Unknown Networks Year 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 Network (CT) Net. of New England 5,829 6,408 7,030 7,643 8,373 9,109 9,796 10,562 11,439 12,090 (NY) Net. of N.Y. 10,071 10,661 11,604 12,575 13,790 15,062 16,231 17,543 18,780 19,847 (NJ) Trans-Atlantic R. C. 5,999 6,401 7,056 7,828 8,626 9,445 10,040 11,004 11,775 12,561 (PA) ESRD Net. Org. #4 7,052 7,698 8,448 9,355 10,180 11,043 11,676 12,684 13,922 14,715 (VA) Mid Atlantic R. C. 7,426 8,219 9,114 10,106 11,312 12,474 13,588 14,438 15,878 17,513 (NC) Southeastern Kidney Council 9,584 10,636 11,951 13,387 14,916 16,671 18,308 20,416 22,462 24,281 (FL) ESRD Net. of Florida 6,627 7,362 8,204 9,211 10,241 11,357 12,288 13,274 14,551 15,851 (MS) Network 8 5,871 6,568 8,417 9,172 10,115 11,150 12,030 13,362 14,606 15,812 (IN) Tri-state R. N. 9,479 10,542 11,675 12,833 14,009 15,446 16,683 17,682 19,594 21,093 (IL) Renal Net. of Illinois 6,279 6,705 7,263 8,051 8,935 9,785 10,677 11,623 12,610 13,395 (MN) Renal Net. of upper midwest 9,158 10,099 11,362 12,547 13,755 15,215 16,499 18,091 19,628 21,173 (MO) ESRD net. #12 5,388 5,868 6,621 7,378 8,055 8,855 9,528 10,336 11,163 11,861 (OK) ESRD net. #13 4,940 5,572 6,164 6,834 7,538 8,295 9,068 10,021 11,096 11,858 (TX) Net. of Texas 8,436 9,406 10,553 11,851 13,244 14,801 16,190 17,905 19,421 21,085 (CO) Inter-mountain ESRD net. 4,772 5,286 5,969 6,585 7,367 8,196 8,938 9,880 10,908 11,713 (WA) Northwest Renal Net. 3,764 4,138 4,689 5,199 5,749 6,141 6,656 7,481 8,315 8,716 (N-CA) Trans-pacific ESRD Net. 5,954 6,573 7,363 8,193 9,092 9,844 10,694 11,807 12,617 13,477 (S-CA) Southern California Net. 8,669 9,301 10,397 11,483 12,654 13,664 14,400 15,880 17,391 18,438 Unknown Network 85 153 313 380 515 729 1,111 2,497 2,890 2,036 -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- 125,383 137,596 154,193 170,611 188,466 207,282 224,401 246,486 269,046 287,515 Table B.19 December 31 Point Prevalence Counts of Reported ESRD Therapy By Network After Dropping Territories and Unknown Networks Year 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 Network (CT) Net. of New England 5,829 6,408 7,030 7,643 8,373 9,109 9,796 10,562 11,439 12,090 (NY) Net. of N.Y. 10,071 10,661 11,604 12,575 13,790 15,062 16,231 17,543 18,780 19,847 (NJ) Trans-Atlantic R. C. 4,485 4,756 5,185 5,751 6,377 6,948 7,379 8,078 8,673 9,214 (PA) ESRD Net. Org. #4 7,052 7,698 8,448 9,355 10,180 11,043 11,676 12,684 13,922 14,715 (VA) Mid Atlantic R. C. 7,426 8,219 9,114 10,106 11,312 12,474 13,588 14,438 15,878 17,513 (NC) Southeastern Kidney Council 9,584 10,636 11,951 13,387 14,916 16,671 18,308 20,416 22,462 24,281 (FL) ESRD Net. of Florida 6,627 7,362 8,204 9,211 10,241 11,357 12,288 13,274 14,551 15,851 (MS) Network 8 5,871 6,568 8,417 9,172 10,115 11,150 12,030 13,362 14,606 15,812 (IN) Tri-state R. N. 9,479 10,542 11,675 12,833 14,009 15,446 16,683 17,682 19,594 21,093 (IL) Renal Net. of Illinois 6,279 6,705 7,263 8,051 8,935 9,785 10,677 11,623 12,610 13,395 (MN) Renal Net. of upper midwest 9,158 10,099 11,362 12,547 13,755 15,215 16,499 18,091 19,628 21,173 (MO) ESRD net. #12 5,388 5,868 6,621 7,378 8,055 8,855 9,528 10,336 11,163 11,861 (OK) ESRD net. #13 4,940 5,572 6,164 6,834 7,538 8,295 9,068 10,021 11,096 11,858 (TX) Net. of Texas 8,436 9,406 10,553 11,851 13,244 14,801 16,190 17,905 19,421 21,085 (CO) Inter-mountain ESRD net. 4,772 5,286 5,969 6,585 7,367 8,196 8,938 9,880 10,908 11,713 (WA) Northwest Renal Net. 3,764 4,138 4,689 5,199 5,749 6,141 6,656 7,481 8,315 8,716 (N-CA) Trans-pacific ESRD Net. 5,907 6,515 7,289 8,099 8,981 9,706 10,545 11,642 12,416 13,241 (S-CA) Southern California Net. 8,669 9,301 10,397 11,483 12,654 13,664 14,400 15,880 17,391 18,438 -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- 123,737 135,740 151,935 168,060 185,591 203,918 220,480 240,898 262,853 281,896 Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31, 1995. Includes Medicare patients only. Table B.20 December 31 Point Prevalence Rates Per Million Population Of Reported ESRD Therapy By Network Adjusted By Age, Race and Sex Year 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 Network (CT) Net. of New England 478.09 518.11 563.74 607.90 660.07 712.43 757.99 808.79 865.93 903.97 (NY) Net. of N.Y. 598.10 627.11 676.98 726.66 791.31 857.23 915.90 981.88 1042.48 1091.58 (NJ) Trans-Atlantic R. C. 618.28 649.49 702.76 772.93 845.92 911.36 955.56 1032.90 1096.03 1150.72 (PA) ESRD Net. Org. #4 590.12 639.20 698.75 765.55 825.15 886.86 930.59 1004.76 1095.60 1151.16 (VA) Mid Atlantic R. C. 611.06 664.47 725.48 791.95 869.81 940.93 1005.92 1051.18 1138.48 1237.05 (NC) Southeastern Kidney Council 633.81 690.95 762.20 834.22 908.35 991.01 1062.06 1156.32 1242.69 1310.84 (FL) ESRD Net. of Florida 574.09 621.15 673.41 736.23 797.93 863.64 912.45 959.85 1026.83 1092.58 (MS) Network 8 544.81 604.37 766.33 821.95 889.83 964.30 1021.58 1116.20 1200.28 1278.39 (IN) Tri-state R. N. 502.30 552.00 607.29 659.17 708.86 770.54 822.94 862.89 945.85 1006.75 (IL) Renal Net. of Illinois 577.69 610.62 655.04 718.77 788.05 853.27 920.88 994.51 1070.65 1128.04 (MN) Renal Net. of upper midwest 495.97 540.33 600.86 653.26 706.99 770.53 823.79 891.22 954.04 1015.06 (MO) ESRD net. #12 477.63 515.13 575.35 633.27 682.60 742.42 789.45 846.70 904.51 951.20 (OK) ESRD net. #13 536.84 604.87 665.89 730.91 793.52 857.58 924.58 1008.24 1102.28 1163.34 (TX) Net. of Texas 546.11 601.05 660.75 725.69 787.45 854.53 909.17 977.43 1031.97 1092.96 (CO) Inter-mountain ESRD net. 454.74 492.05 542.16 579.51 628.07 673.56 707.01 748.61 794.03 823.87 (WA) Northwest Renal Net. 411.04 440.90 487.34 526.99 564.57 587.15 620.00 679.94 739.19 757.87 (N-CA) Trans-pacific ESRD Net. 562.92 605.47 660.76 718.91 749.71 793.68 848.21 921.48 965.26 1009.65 (S-CA) Southern California Net. 492.72 516.16 563.84 612.13 677.82 718.63 747.95 814.63 879.52 917.04 Table B.21 Standard Errors For Adjusted December 31 Point Prevalence Rates Per Million Population Of Reported ESRD Therapy By Network Adjusted By Age, Race and Sex Year 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 Network (CT) Net. of New England 6.40 6.59 6.82 7.02 7.26 7.49 7.67 7.87 8.09 8.21 (NY) Net. of N.Y. 6.07 6.16 6.35 6.53 6.77 7.01 7.20 7.41 7.60 7.74 (NJ) Trans-Atlantic R. C. 9.44 9.59 9.90 10.32 10.67 10.98 11.14 11.49 11.75 11.97 (PA) ESRD Net. Org. #4 7.17 7.40 7.70 8.00 8.23 8.47 8.62 8.92 9.27 9.47 (VA) Mid Atlantic R. C. 7.20 7.42 7.67 7.93 8.21 8.44 8.63 8.74 9.02 9.33 (NC) Southeastern Kidney Council 6.58 6.78 7.04 7.26 7.47 7.69 7.85 8.08 8.27 8.39 (FL) ESRD Net. of Florida 7.17 7.34 7.52 7.75 7.93 8.13 8.24 8.33 8.50 8.66 (MS) Network 8 7.23 7.56 8.44 8.66 8.90 9.16 9.32 9.65 9.91 10.14 (IN) Tri-state R. N. 5.23 5.44 5.67 5.86 6.02 6.21 6.38 6.49 6.75 6.92 (IL) Renal Net. of Illinois 7.40 7.54 7.76 8.07 8.37 8.65 8.92 9.22 9.52 9.73 (MN) Renal Net. of upper midwest 5.27 5.45 5.70 5.88 6.06 6.27 6.42 6.62 6.80 6.97 (MO) ESRD net. #12 6.61 6.81 7.14 7.43 7.64 7.91 8.10 8.33 8.55 8.72 (OK) ESRD net. #13 7.74 8.19 8.55 8.90 9.18 9.43 9.71 10.06 10.45 10.66 (TX) Net. of Texas 6.08 6.31 6.52 6.73 6.89 7.05 7.15 7.30 7.40 7.51 (CO) Inter-mountain ESRD net. 6.70 6.87 7.10 7.21 7.36 7.47 7.49 7.53 7.60 7.60 (WA) Northwest Renal Net. 6.86 6.98 7.22 7.40 7.50 7.53 7.62 7.87 8.10 8.11 (N-CA) Trans-pacific ESRD Net. 7.53 7.68 7.89 8.12 7.96 8.09 8.27 8.54 8.65 8.76 (S-CA) Southern California Net. 5.37 5.42 5.58 5.75 6.06 6.17 6.24 6.46 6.66 6.74 Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31, 1995. Includes Medicare patients only. Table B.22 December 31 Point Prevalence Counts Of Reported ESRD Therapy By Age, By Sex, By Race 1991-1993 ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 5347 1472 186 103 7108| 3775 938 192 81 4986| 9122 2410 378 184 12094| | 20-44 | 66926 31993 3050 1097 103066| 48686 20997 2600 855 73138|115612 52990 5650 1952 176204| | 45-64 | 74291 41867 3525 2026 121709| 58112 38113 3185 2005 101415|132403 79980 6710 4031 223124| | 65-74 | 43760 15588 1676 597 61621| 39071 23708 1917 1040 65736| 82831 39296 3593 1637 127357| | 75 plus | 26545 6537 946 245 34273| 22345 11157 976 349 34827| 48890 17694 1922 594 69100| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 216869 97457 9383 4068 327777|171989 94913 8870 4330 280102|388858 192370 18253 8398 607879| ----------------------------------------------------------------------------------------------------------------------- 1994-1996 ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 6196 1963 233 121 8513| 4294 1184 228 111 5817| 10490 3147 461 232 14330| | 20-44 | 76042 39418 3845 1457 120762| 54948 27778 3444 1191 87361|130990 67196 7289 2648 208123| | 45-64 | 98750 57575 5402 2957 164684| 74915 50705 4774 2840 133234|173665 108280 10176 5797 297918| | 65-74 | 55362 20481 2605 935 79383| 49154 30774 2913 1492 84333|104516 51255 5518 2427 163716| | 75 plus | 37787 9117 1674 341 48919| 31467 15559 1801 578 49405| 69254 24676 3475 919 98324| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 274137 128554 13759 5811 422261|214778 126000 13160 6212 360150|488915 254554 26919 12023 782411| ----------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31, 1995. Includes Medicare patients only. Table B.23 December 31 Point Prevalence Rates Per Million Population Of Reported ESRD Therapy Specific Rates By Sex, By Race, By Age And Rates Adjusted For Age, Race, And Sex 1991-1993 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 59 85 44 80 | 44 55 48 65 | 52 72 48 76 | 63 47 | 55 | | 20-44 | 527 1734 551 836 | 391 1025 445 655 | 453 1433 505 776 | 693 474 | 580 | | 45-64 | 1203 6357 1759 4374 | 894 4656 1385 3993 | 1076 5743 1683 4576 | 1967 1478 | 1714 | | 65-74 | 1990 8006 3543 5616 | 1419 8605 3102 7894 | 1703 8308 3334 6716 | 2842 2442 | 2640 | | 75 plus | 1955 6023 3804 4256 | 911 5387 3118 3761 | 1320 5247 3195 3647 | 2362 1464 | 1904 | | All Age | 689 2148 756 1262 | 526 1885 679 1322 | 606 2010 717 1292 | 872 711 | 790 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 710 2918 1057 1893 | 493 2261 859 1864 | 591 2582 948 1883 | 952 682 | 804 | ------------------------------------------------------------------------------------------------------------------------- 1994-1996 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 66 109 50 91 | 48 67 51 85 | 58 89 53 89 | 72 52 | 62 | | 20-44 | 603 2082 640 1073 | 446 1328 537 891 | 507 1716 590 1011 | 786 552 | 666 | | 45-64 | 1480 7873 2224 5776 | 1075 5577 1712 5108 | 1337 7162 2147 6024 | 2478 1818 | 2138 | | 65-74 | 2486 10065 4795 8123 | 1795 10830 3927 10671 | 2139 10506 4403 9324 | 3590 3097 | 3341 | | 75 plus | 2542 7807 5567 5027 | 1214 7097 4456 5316 | 1748 6921 4640 4751 | 3107 1979 | 2532 | | All Age | 849 2711 989 1718 | 643 2401 890 1810 | 744 2548 938 1764 | 1089 890 | 987 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 864 3612 1379 2505 | 596 2841 1102 2499 | 716 3218 1226 2513 | 1166 838 | 987 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995 U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.24 Standard Errors For Adjusted December 31 Point Prevalence Rates Per Million Population Of Reported ESRD Therapy By Sex, By Race, By Age Adjusted For Age, Race, And Sex 1991-1993 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 0.8 2.2 3.2 7.9 | 0.7 1.8 3.4 7.2 | 0.5 1.4 2.5 5.6 | 0.7 0.6 | 0.5 | | 20-44 | 2.0 9.6 9.9 25.2 | 1.7 7.0 8.7 22.4 | 1.3 6.2 6.7 17.6 | 2.1 1.7 | 1.3 | | 45-64 | 4.4 31.0 29.6 97.1 | 3.7 23.8 24.5 89.1 | 2.9 20.7 21.2 74.2 | 5.8 4.7 | 3.7 | | 65-74 | 9.5 64.1 86.5 229.8 | 7.1 55.8 70.8 244.8 | 5.9 42.8 56.6 168.3 | 12.0 9.8 | 7.7 | | 75 plus | 11.9 74.5 123.6 271.9 | 6.0 51.0 99.8 201.3 | 6.5 43.4 78.9 160.4 | 14.4 8.6 | 8.3 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1.5 9.6 11.8 31.6 | 1.1 7.3 9.6 29.1 | 0.9 5.9 7.5 21.4 | 1.6 1.2 | 1.0 | ------------------------------------------------------------------------------------------------------------------------- 1994-1996 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 0.8 2.4 3.2 8.2 | 0.7 1.9 3.4 8.1 | 0.5 1.6 2.4 5.9 | 0.7 0.6 | 0.5 | | 20-44 | 2.1 10.4 10.3 28.1 | 1.9 7.9 9.1 25.8 | 1.4 6.6 6.9 19.7 | 2.2 1.8 | 1.4 | | 45-64 | 4.7 32.8 30.2 106.2 | 3.9 24.7 24.7 95.8 | 3.2 22.4 22.2 82.1 | 6.3 5.1 | 4.0 | | 65-74 | 10.5 70.3 93.9 265.6 | 8.0 61.7 72.7 276.2 | 6.6 47.3 60.3 190.9 | 13.2 10.9 | 8.5 | | 75 plus | 13.0 81.7 136.0 272.2 | 6.8 56.8 105.0 221.1 | 7.2 48.2 84.4 165.3 | 15.8 9.6 | 9.1 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1.6 10.4 12.6 34.6 | 1.2 8.0 10.0 32.5 | 1.0 6.4 7.9 23.7 | 1.8 1.4 | 1.1 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995 U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.25 December 31 Point Prevalence Counts Of Reported ESRD Therapy By Age, By Sex, By Race, By Primary Disease Causing ESRD 1991-1993 Diabetes ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 15 * * * 25| 17 * 0 * 26| 32 13 * * 51| | 20-44 | 18038 3439 332 280 22089| 13453 3252 262 240 17207| 31491 6691 594 520 39296| | 45-64 | 22798 11404 1168 1221 36591| 19343 15041 953 1375 36712| 42141 26445 2121 2596 73303| | 65-74 | 11301 4718 631 317 16967| 14230 10319 870 749 26168| 25531 15037 1501 1066 43135| | 75 plus | 3681 1385 230 86 5382| 4950 3286 290 180 8706| 8631 4671 520 266 14088| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 55833 20951 2364 1906 81054| 51993 31906 2375 2545 88819|107826 52857 4739 4451 169873| ----------------------------------------------------------------------------------------------------------------------- Hypertension ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 88 103 * * 202| 128 51 * * 190| 216 154 * 16 392| | 20-44 | 5484 12692 501 128 18805| 3089 5573 352 86 9100| 8573 18265 853 214 27905| | 45-64 | 11930 19290 678 269 32167| 7581 13069 586 167 21403| 19511 32359 1264 436 53570| | 65-74 | 14201 7129 494 121 21945| 9385 9147 441 110 19083| 23586 16276 935 231 41028| | 75 plus | 12333 3465 408 68 16274| 9127 5847 393 95 15462| 21460 9312 801 163 31736| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 44036 42679 2083 595 89393| 29310 33687 1776 465 65238| 73346 76366 3859 1060 154631| ----------------------------------------------------------------------------------------------------------------------- Glomeruloneph. ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 1298 511 57 28 1894| 1222 404 80 43 1749| 2520 915 137 71 3643| | 20-44 | 20714 8973 1412 376 31475| 13118 5452 1089 251 19910| 33832 14425 2501 627 51385| | 45-64 | 17381 4792 1002 284 23459| 9808 3499 798 203 14308| 27189 8291 1800 487 37767| | 65-74 | 7348 1103 266 72 8789| 4726 1211 249 45 6231| 12074 2314 515 117 15020| | 75 plus | 3704 369 122 22 4217| 2858 599 116 23 3596| 6562 968 238 45 7813| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 50445 15748 2859 782 69834| 31732 11165 2332 565 45794| 82177 26913 5191 1347 115628| ----------------------------------------------------------------------------------------------------------------------- Cystic Kidney ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 310 31 * * 353| 264 27 15 * 309| 574 58 19 11 662| | 20-44 | 2604 287 86 29 3006| 1792 338 47 26 2203| 4396 625 133 55 5209| | 45-64 | 8086 928 177 67 9258| 7487 1085 171 62 8805| 15573 2013 348 129 18063| | 65-74 | 2159 252 60 * 2479| 2858 284 65 13 3220| 5017 536 125 21 5699| | 75 plus | 627 87 12 * 729| 724 80 * * 813| 1351 167 18 * 1542| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 13786 1585 339 115 15825| 13125 1814 304 107 15350| 26911 3399 643 222 31175| ----------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table B.25 (Continued) December 31 Point Prevalence Counts Of Reported ESRD Therapy By Age, By Sex, By Race, By Primary Disease Causing ESRD 1991-1993 Other Urologic ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 565 128 27 * 728| 211 14 * * 229| 776 142 29 10 957| | 20-44 | 1843 328 47 26 2244| 1118 142 37 26 1323| 2961 470 84 52 3567| | 45-64 | 1031 260 44 13 1348| 899 200 34 * 1140| 1930 460 78 20 2488| | 65-74 | 1113 254 36 * 1412| 558 126 26 * 719| 1671 380 62 18 2131| | 75 plus | 1133 228 35 11 1407| 388 69 23 0 480| 1521 297 58 11 1887| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 5685 1198 189 67 7139| 3174 551 122 44 3891| 8859 1749 311 111 11030| ----------------------------------------------------------------------------------------------------------------------- Other Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 2412 509 78 41 3040| 1439 338 68 19 1864| 3851 847 146 60 4904| | 20-44 | 10706 3462 344 142 14654| 10286 4575 574 142 15577| 20992 8037 918 284 30231| | 45-64 | 6307 2035 196 73 8611| 7553 2415 395 85 10448| 13860 4450 591 158 19059| | 65-74 | 3843 787 79 27 4736| 4038 879 134 48 5099| 7881 1666 213 75 9835| | 75 plus | 2524 438 67 26 3055| 2115 440 69 25 2649| 4639 878 136 51 5704| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 25792 7231 764 309 34096| 25431 8647 1240 319 35637| 51223 15878 2004 628 69733| ----------------------------------------------------------------------------------------------------------------------- Unknown Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 513 139 15 * 674| 363 67 22 * 458| 876 206 37 13 1132| | 20-44 | 4919 2009 289 99 7316| 3754 1160 216 63 5193| 8673 3169 505 162 12509| | 45-64 | 4024 1798 246 77 6145| 3133 1493 219 71 4916| 7157 3291 465 148 11061| | 65-74 | 2602 729 86 36 3453| 2077 898 108 47 3130| 4679 1627 194 83 6583| | 75 plus | 1982 364 62 29 2437| 1597 503 63 17 2180| 3579 867 125 46 4617| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 14040 5039 698 248 20025| 10924 4121 628 204 15877| 24964 9160 1326 452 35902| ----------------------------------------------------------------------------------------------------------------------- Missing Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 146 46 0 0 192| 131 29 * 0 161| 277 75 * 0 353| | 20-44 | 2618 803 39 17 3477| 2076 505 23 21 2625| 4694 1308 62 38 6102| | 45-64 | 2734 1360 14 22 4130| 2308 1311 29 35 3683| 5042 2671 43 57 7813| | 65-74 | 1193 616 24 * 1840| 1199 844 24 19 2086| 2392 1460 48 26 3926| | 75 plus | 561 201 10 0 772| 586 333 16 * 941| 1147 534 26 * 1713| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 7252 3026 87 46 10411| 6300 3022 93 81 9496| 13552 6048 180 127 19907| ----------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table B.25 (Continued) December 31 Point Prevalence Counts Of Reported ESRD Therapy By Age, By Sex, By Race, By Primary Disease Causing ESRD 1994-1996 Diabetes ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 29 12 * * 47| 34 20 * * 59| 63 32 * * 106| | 20-44 | 20816 4673 428 363 26280| 15345 4658 346 361 20710| 36161 9331 774 724 46990| | 45-64 | 34637 17121 1888 1841 55487| 28160 21836 1511 1999 53506| 62797 38957 3399 3840 108993| | 65-74 | 17378 7342 1082 568 26370| 20806 15125 1425 1128 38484| 38184 22467 2507 1696 64854| | 75 plus | 6685 2378 497 130 9690| 8428 5548 681 335 14992| 15113 7926 1178 465 24682| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 79545 31526 3898 2905 117874| 72773 47187 3967 3824 127751|152318 78713 7865 6729 245625| ----------------------------------------------------------------------------------------------------------------------- Hypertension ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 91 101 0 * 201| 132 60 * * 203| 223 161 * 15 404| | 20-44 | 6651 15536 621 214 23022| 3685 7272 451 142 11550| 10336 22808 1072 356 34572| | 45-64 | 15255 25727 1071 377 42430| 9216 16648 943 246 27053| 24471 42375 2014 623 69483| | 65-74 | 16752 9071 714 170 26707| 10991 11221 692 159 23063| 27743 20292 1406 329 49770| | 75 plus | 17088 4817 675 82 22662| 12661 7688 638 147 21134| 29749 12505 1313 229 43796| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 55837 55252 3081 852 115022| 36685 42889 2729 700 83003| 92522 98141 5810 1552 198025| ----------------------------------------------------------------------------------------------------------------------- Glomeruloneph. ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 1449 676 82 38 2245| 1351 449 93 53 1946| 2800 1125 175 91 4191| | 20-44 | 22981 10603 1828 447 35859| 14486 7050 1527 343 23406| 37467 17653 3355 790 59265| | 45-64 | 21656 6983 1452 374 30465| 12415 4745 1155 284 18599| 34071 11728 2607 658 49064| | 65-74 | 8689 1425 431 83 10628| 5529 1468 333 70 7400| 14218 2893 764 153 18028| | 75 plus | 5127 534 227 51 5939| 3575 742 215 34 4566| 8702 1276 442 85 10505| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 59902 20221 4020 993 85136| 37356 14454 3323 784 55917| 97258 34675 7343 1777 141053| ----------------------------------------------------------------------------------------------------------------------- Cystic Kidney ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 326 41 * 11 386| 301 52 28 * 384| 627 93 36 14 770| | 20-44 | 2805 351 70 40 3266| 2036 427 71 31 2565| 4841 778 141 71 5831| | 45-64 | 10063 1215 281 81 11640| 8854 1395 194 82 10525| 18917 2610 475 163 22165| | 65-74 | 2852 304 75 10 3241| 3426 377 74 16 3893| 6278 681 149 26 7134| | 75 plus | 834 108 30 * 976| 1010 139 30 * 1185| 1844 247 60 10 2161| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 16880 2019 464 146 19509| 15627 2390 397 138 18552| 32507 4409 861 284 38061| ----------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table B.25 (Continued) December 31 Point Prevalence Counts Of Reported ESRD Therapy By Age, By Sex, By Race, By Primary Disease Causing ESRD 1994-1996 Other Urologic ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 660 181 25 * 872| 277 24 * * 307| 937 205 28 * 1179| | 20-44 | 2404 416 75 38 2933| 1648 203 54 31 1936| 4052 619 129 69 4869| | 45-64 | 1542 334 76 21 1973| 1356 256 82 * 1701| 2898 590 158 28 3674| | 65-74 | 1328 284 38 11 1661| 738 157 44 * 945| 2066 441 82 17 2606| | 75 plus | 1489 233 51 19 1792| 537 91 22 * 655| 2026 324 73 24 2447| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 7423 1448 265 95 9231| 4556 731 205 52 5544| 11979 2179 470 147 14775| ----------------------------------------------------------------------------------------------------------------------- Other Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 2871 698 101 40 3710| 1601 414 74 38 2127| 4472 1112 175 78 5837| | 20-44 | 12489 4764 421 219 17893| 11709 6260 696 190 18855| 24198 11024 1117 409 36748| | 45-64 | 8513 2987 268 151 11919| 9563 3392 543 131 13629| 18076 6379 811 282 25548| | 65-74 | 4948 916 121 46 6031| 4843 1066 172 62 6143| 9791 1982 293 108 12174| | 75 plus | 3857 541 91 31 4520| 3048 591 85 25 3749| 6905 1132 176 56 8269| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 32678 9906 1002 487 44073| 30764 11723 1570 446 44503| 63442 21629 2572 933 88576| ----------------------------------------------------------------------------------------------------------------------- Unknown Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 528 169 11 11 719| 407 93 17 * 524| 935 262 28 18 1243| | 20-44 | 5551 2332 346 116 8345| 4105 1392 265 78 5840| 9656 3724 611 194 14185| | 45-64 | 4697 2163 333 88 7281| 3581 1708 308 78 5675| 8278 3871 641 166 12956| | 65-74 | 2732 792 122 45 3691| 2187 908 161 40 3296| 4919 1700 283 85 6987| | 75 plus | 2421 393 100 24 2938| 1883 589 116 22 2610| 4304 982 216 46 5548| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 15929 5849 912 284 22974| 12163 4690 867 225 17945| 28092 10539 1779 509 40919| ----------------------------------------------------------------------------------------------------------------------- Missing Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 242 85 * * 333| 191 72 * 0 267| 433 157 * * 600| | 20-44 | 2345 743 56 20 3164| 1934 516 34 15 2499| 4279 1259 90 35 5663| | 45-64 | 2387 1045 33 24 3489| 1770 725 38 13 2546| 4157 1770 71 37 6035| | 65-74 | 683 347 22 * 1054| 634 452 12 11 1109| 1317 799 34 13 2163| | 75 plus | 286 113 * 0 402| 325 171 14 * 514| 611 284 17 * 916| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 5943 2333 117 49 8442| 4854 1936 102 43 6935| 10797 4269 219 92 15377| ----------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table B.26 December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD Specific Rates By Sex, By Race, By Age And Rates Adjusted For Age, Race, And Sex 1991-1993 Diabetes ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | * * * * | * * 0 * | * * * * | * * | * | | 20-44 | 1421 1864 599 2134 | 1081 1588 448 1841 | 1222 1829 538 2154 | 1457 1113 | 1282 | | 45-64 | 3691 17316 5828 26364 | 2977 18377 4146 27384 | 3441 19280 5726 30105 | 5983 5528 | 5754 | | 65-74 | 5139 24234 13342 29821 | 5169 37456 14080 56858 | 5134 30780 13586 43037 | 7992 9964 | 9022 | | 75 plus | 2711 12762 9249 14942 | 2018 15866 9264 19399 | 2027 12429 7928 14687 | 3632 3689 | 3668 | | All Age | 1802 6644 2896 9220 | 1484 7785 2506 11454 | 1638 7292 2696 10487 | 2331 2150 | 2246 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1802 6644 2896 9220 | 1484 7785 2506 11454 | 1638 7292 2696 10487 | 2331 2150 | 2246 | ------------------------------------------------------------------------------------------------------------------------- Hypertension ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | * 59 * * | 14 30 * * | 12 47 * 65 | 17 17 | 17 | | 20-44 | 432 6880 905 975 | 248 2722 602 659 | 335 5074 769 866 | 1332 589 | 944 | | 45-64 | 1931 29290 3383 5808 | 1167 15968 2549 3325 | 1634 23362 3201 4913 | 5701 3270 | 4436 | | 65-74 | 6458 36618 10445 11383 | 3409 33202 7137 8350 | 4961 35104 8937 10018 | 10560 7407 | 8949 | | 75 plus | 9083 31929 16407 11815 | 3722 28232 12555 10238 | 6058 28236 14037 10900 | 11650 6825 | 9189 | | All Age | 1515 13184 2742 3124 | 782 8251 1966 2135 | 1094 10634 2298 2588 | 2746 1533 | 2065 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1515 13184 2742 3124 | 782 8251 1966 2135 | 1094 10634 2298 2588 | 2746 1533 | 2065 | ------------------------------------------------------------------------------------------------------------------------- Glomeruloneph. ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 143 295 137 218 | 143 239 201 345 | 147 279 178 296 | 168 165 | 166 | | 20-44 | 1631 4864 2551 2866 | 1054 2663 1863 1925 | 1325 3841 2233 2452 | 2097 1291 | 1682 | | 45-64 | 2814 7276 5000 6132 | 1509 4275 3472 4042 | 2167 5671 4200 5048 | 3488 1959 | 2704 | | 65-74 | 3341 5665 5624 6773 | 1716 4395 4029 3416 | 2513 4989 4830 5008 | 3745 2150 | 2931 | | 75 plus | 2728 3400 4906 3822 | 1165 2892 3705 2478 | 1758 2874 3918 2752 | 2614 1384 | 1987 | | All Age | 1625 4108 2733 3154 | 939 2452 1980 2055 | 1261 3263 2335 2577 | 1959 1147 | 1528 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1625 4108 2733 3154 | 939 2452 1980 2055 | 1261 3263 2335 2577 | 1959 1147 | 1528 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.26 (Continued) December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD Specific Rates By Sex, By Race, By Age And Rates Adjusted For Age, Race, And Sex 1991-1993 Cystic Kidney ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 34 17 * * | 30 16 37 * | 33 17 24 42 | 31 29 | 30 | | 20-44 | 205 155 155 221 | 144 165 80 199 | 175 172 123 229 | 202 145 | 173 | | 45-64 | 1309 1409 883 1446 | 1152 1325 744 1234 | 1268 1412 878 1354 | 1344 1204 | 1273 | | 65-74 | 981 1294 1268 * | 1038 1030 1051 986 | 998 1132 1163 837 | 1011 1028 | 1019 | | 75 plus | 461 801 482 * | 295 386 * * | 338 530 255 * | 449 272 | 358 | | All Age | 446 488 363 482 | 382 430 277 425 | 413 455 317 454 | 446 384 | 414 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 446 488 363 482 | 382 430 277 425 | 413 455 317 454 | 446 384 | 414 | ------------------------------------------------------------------------------------------------------------------------- Other Urologic ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 62 73 65 * | 24 * * * | 44 41 35 39 | 65 22 | 43 | | 20-44 | 145 177 84 198 | 89 69 63 199 | 117 122 74 191 | 148 87 | 117 | | 45-64 | 166 394 219 280 | 138 244 147 * | 157 344 191 247 | 210 156 | 182 | | 65-74 | 506 1304 761 * | 202 457 420 * | 357 889 631 727 | 635 248 | 436 | | 75 plus | 834 2100 1407 1911 | 158 333 734 0 | 470 1164 924 919 | 989 184 | 576 | | All Age | 189 379 227 312 | 92 129 126 155 | 134 238 171 218 | 207 96 | 144 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 189 379 227 312 | 92 129 126 155 | 134 238 171 218 | 207 96 | 144 | ------------------------------------------------------------------------------------------------------------------------- Other Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 267 294 188 319 | 168 200 171 152 | 221 253 187 249 | 273 177 | 224 | | 20-44 | 843 1876 621 1082 | 826 2235 982 1089 | 829 2088 810 1087 | 971 1006 | 990 | | 45-64 | 1021 3090 978 1576 | 1162 2950 1718 1692 | 1113 3040 1392 1744 | 1311 1430 | 1371 | | 65-74 | 1747 4042 1670 2540 | 1466 3190 2168 3643 | 1607 3626 1947 3121 | 2057 1724 | 1886 | | 75 plus | 1858 4036 2694 4517 | 862 2124 2204 2694 | 1252 2921 2151 3342 | 2047 1003 | 1512 | | All Age | 831 1982 766 1261 | 751 1872 1050 1234 | 784 1908 906 1241 | 952 889 | 913 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 831 1982 766 1261 | 751 1872 1050 1234 | 784 1908 906 1241 | 952 889 | 913 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.26 (Continued) December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD Specific Rates By Sex, By Race, By Age And Rates Adjusted For Age, Race, And Sex 1991-1993 Unknown Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 56 80 36 * | 42 39 55 * | 50 61 48 54 | 60 44 | 52 | | 20-44 | 387 1089 522 754 | 301 566 369 483 | 341 849 449 631 | 488 338 | 410 | | 45-64 | 651 2730 1227 1662 | 482 1824 952 1414 | 580 2356 1128 1709 | 973 700 | 832 | | 65-74 | 1183 3744 1818 3386 | 754 3259 1747 3567 | 974 3475 1795 3352 | 1554 1133 | 1339 | | 75 plus | 1459 3354 2493 5038 | 651 2428 2012 1832 | 999 2756 2286 3278 | 1699 893 | 1287 | | All Age | 461 1467 741 1177 | 314 966 593 843 | 380 1205 659 988 | 579 388 | 474 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 461 1467 741 1177 | 314 966 593 843 | 380 1205 659 988 | 579 388 | 474 | ------------------------------------------------------------------------------------------------------------------------- Missing Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 16 26 0 0 | 15 17 * 0 | 16 22 * 0 | 17 15 | 16 | | 20-44 | 206 435 70 129 | 166 246 39 161 | 184 355 56 148 | 232 170 | 200 | | 45-64 | 442 2065 69 475 | 355 1601 126 697 | 405 1966 116 636 | 658 531 | 592 | | 65-74 | 542 3164 507 * | 435 3063 388 1442 | 484 3082 451 1057 | 866 766 | 815 | | 75 plus | 413 1852 402 0 | 238 1607 511 * | 299 1563 454 * | 542 390 | 464 | | All Age | 235 928 103 203 | 184 727 98 338 | 207 823 100 277 | 298 232 | 263 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 235 928 103 203 | 184 727 98 338 | 207 823 100 277 | 298 232 | 263 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.26 (Continued) December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD Specific Rates By Sex, By Race, By Age And Rates Adjusted For Age, Race, And Sex 1994-1996 Diabetes ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | * * * * | * 11 * * | * * * * | * * | * | | 20-44 | 1651 2468 712 2673 | 1246 2227 539 2702 | 1368 2382 631 2852 | 1673 1299 | 1482 | | 45-64 | 5194 23411 7773 35966 | 4042 24019 5421 35959 | 4889 26612 7711 40962 | 8513 7588 | 8044 | | 65-74 | 7803 36082 19920 49349 | 7600 53231 19210 80678 | 7692 44809 19726 64345 | 12133 14409 | 13326 | | 75 plus | 4498 20364 16529 19165 | 3252 25306 16849 30811 | 3372 20124 14876 22261 | 6041 6085 | 6074 | | All Age | 2468 9462 4249 13104 | 2007 10962 3635 16087 | 2226 10319 3928 14821 | 3233 2953 | 3097 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 2468 9462 4249 13104 | 2007 10962 3635 16087 | 2226 10319 3928 14821 | 3233 2953 | 3097 | ------------------------------------------------------------------------------------------------------------------------- Hypertension ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | * 56 0 * | 15 34 * * | 12 46 * 58 | 16 18 | 17 | | 20-44 | 527 8206 1033 1576 | 299 3477 703 1063 | 397 5904 872 1369 | 1539 712 | 1108 | | 45-64 | 2287 35180 4409 7365 | 1322 18312 3383 4425 | 1964 28080 4326 6212 | 6961 3863 | 5350 | | 65-74 | 7522 44579 13145 14769 | 4015 39491 9329 11372 | 5792 42438 11427 13220 | 12612 8832 | 10678 | | 75 plus | 11498 41251 22450 12089 | 4885 35068 15785 13520 | 7842 36285 18448 12514 | 15000 8840 | 11855 | | All Age | 1842 15957 3533 3909 | 946 9910 2531 2925 | 1327 12815 2961 3403 | 3328 1852 | 2498 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1842 15957 3533 3909 | 946 9910 2531 2925 | 1327 12815 2961 3403 | 3328 1852 | 2498 | ------------------------------------------------------------------------------------------------------------------------- Glomeruloneph. ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 155 376 177 285 | 153 257 209 410 | 157 323 203 358 | 188 174 | 181 | | 20-44 | 1823 5600 3042 3292 | 1176 3370 2381 2567 | 1458 4491 2719 2979 | 2329 1488 | 1896 | | 45-64 | 3247 9548 5978 7306 | 1782 5219 4144 5108 | 2542 7243 5056 6305 | 4211 2347 | 3254 | | 65-74 | 3901 7003 7934 7211 | 2019 5166 4489 5006 | 2944 6086 6266 6013 | 4481 2535 | 3487 | | 75 plus | 3449 4572 7549 7518 | 1379 3384 5319 3127 | 2226 3638 5854 4563 | 3472 1677 | 2557 | | All Age | 1861 4977 3446 3816 | 1074 2991 2436 2696 | 1440 3957 2901 3213 | 2281 1342 | 1779 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1861 4977 3446 3816 | 1074 2991 2436 2696 | 1440 3957 2901 3213 | 2281 1342 | 1779 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.26 (Continued) December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD Specific Rates By Sex, By Race, By Age And Rates Adjusted For Age, Race, And Sex 1994-1996 Cystic Kidney ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 35 22 * 82 | 34 29 63 * | 34 26 41 50 | 33 34 | 34 | | 20-44 | 222 185 116 294 | 165 204 110 232 | 187 199 117 275 | 210 165 | 187 | | 45-64 | 1509 1661 1157 1582 | 1270 1534 696 1475 | 1452 1688 985 1629 | 1579 1358 | 1466 | | 65-74 | 1280 1494 1380 868 | 1251 1326 997 1144 | 1258 1400 1176 973 | 1298 1244 | 1270 | | 75 plus | 561 924 997 * | 389 634 742 * | 422 708 700 434 | 554 387 | 468 | | All Age | 519 575 438 562 | 438 530 314 514 | 476 549 371 539 | 520 443 | 480 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 519 575 438 562 | 438 530 314 514 | 476 549 371 539 | 520 443 | 480 | ------------------------------------------------------------------------------------------------------------------------- Other Urologic ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 70 100 53 * | 31 13 * * | 51 57 31 * | 74 28 | 51 | | 20-44 | 190 219 124 279 | 133 97 84 232 | 161 157 103 251 | 193 127 | 159 | | 45-64 | 231 456 312 410 | 194 281 294 * | 222 398 341 312 | 284 216 | 249 | | 65-74 | 596 1395 699 955 | 269 552 593 * | 435 980 652 695 | 716 319 | 513 | | 75 plus | 1001 1995 1696 2801 | 207 415 544 * | 574 1244 1079 1610 | 1161 231 | 684 | | All Age | 238 423 274 435 | 130 161 168 177 | 177 275 213 282 | 256 133 | 186 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 238 423 274 435 | 130 161 168 177 | 177 275 213 282 | 256 133 | 186 | ------------------------------------------------------------------------------------------------------------------------- Other Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 308 388 218 301 | 182 237 166 294 | 246 315 201 302 | 317 192 | 253 | | 20-44 | 991 2516 700 1612 | 951 2993 1085 1422 | 957 2759 898 1527 | 1173 1200 | 1188 | | 45-64 | 1276 4084 1103 2950 | 1372 3731 1948 2356 | 1365 3915 1583 2751 | 1685 1727 | 1706 | | 65-74 | 2221 4501 2227 3996 | 1769 3751 2318 4434 | 1996 4177 2278 4172 | 2548 2063 | 2299 | | 75 plus | 2595 4632 3026 4570 | 1176 2695 2103 2299 | 1771 3510 2375 3358 | 2750 1332 | 2025 | | All Age | 1026 2513 890 1860 | 884 2402 1141 1568 | 944 2439 1009 1693 | 1188 1068 | 1117 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1026 2513 890 1860 | 884 2402 1141 1568 | 944 2439 1009 1693 | 1188 1068 | 1117 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.26 (Continued) December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD Specific Rates By Sex, By Race, By Age And Rates Adjusted For Age, Race, And Sex 1994-1996 Unknown Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 56 94 23 82 | 46 53 38 * | 52 74 33 69 | 61 47 | 54 | | 20-44 | 440 1231 575 854 | 333 665 413 583 | 378 951 493 724 | 544 374 | 456 | | 45-64 | 704 2957 1371 1719 | 514 1878 1105 1403 | 629 2494 1323 1658 | 1056 747 | 897 | | 65-74 | 1226 3892 2246 3909 | 798 3195 2170 2860 | 1014 3559 2230 3351 | 1635 1173 | 1399 | | 75 plus | 1629 3365 3325 3538 | 726 2686 2870 2023 | 1126 2893 2824 2597 | 1832 1032 | 1424 | | All Age | 504 1577 857 1186 | 341 1033 713 848 | 414 1296 782 1006 | 631 422 | 516 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 504 1577 857 1186 | 341 1033 713 848 | 414 1296 782 1006 | 631 422 | 516 | ------------------------------------------------------------------------------------------------------------------------- Missing Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 26 47 * * | 21 41 * 0 | 23 44 * * | 28 23 | 25 | | 20-44 | 186 392 93 147 | 157 246 53 112 | 165 321 73 132 | 204 159 | 181 | | 45-64 | 357 1428 135 468 | 254 797 136 233 | 306 1192 149 415 | 497 332 | 412 | | 65-74 | 306 1705 405 * | 231 1590 161 786 | 265 1615 275 472 | 479 398 | 437 | | 75 plus | 192 967 * 0 | 125 780 346 * | 149 811 247 * | 267 207 | 236 | | All Age | 182 633 101 178 | 140 426 83 171 | 160 525 93 178 | 225 166 | 194 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 182 633 101 178 | 140 426 83 171 | 160 525 93 178 | 225 166 | 194 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.27 Standard Errors For Adjusted December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD By Sex, By Race, By Age Adjusted For Age, Race, And Sex 1991-1993 Diabetes ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 0.4 * * * | 0.4 * 0.0 * | 0.3 1.1 * * | 0.4 0.4 | 0.3 | | 20-44 | 10.5 31.7 32.9 127.5 | 9.3 27.8 27.7 118.8 | 6.9 22.5 22.1 95.0 | 9.8 8.5 | 6.4 | | 45-64 | 24.4 162.1 170.5 754.5 | 21.4 149.8 134.3 738.5 | 16.9 120.5 128.0 606.6 | 32.4 29.3 | 21.8 | | 65-74 | 48.3 352.8 531.1 1674.9 | 43.3 368.7 477.3 2077.5 | 32.3 256.0 357.0 1335.0 | 64.5 63.8 | 45.4 | | 75 plus | 44.6 342.9 609.8 1611.3 | 28.6 276.7 544.0 1445.9 | 23.6 197.9 373.3 950.0 | 56.3 43.5 | 35.3 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 7.6 46.9 62.8 220.1 | 6.5 43.7 53.6 231.2 | 4.9 32.0 41.1 161.6 | 8.2 7.2 | 5.4 | ------------------------------------------------------------------------------------------------------------------------- Hypertension ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 1.0 5.8 * * | 1.3 4.2 * * | 0.8 3.7 * 16.4 | 1.2 1.3 | 0.8 | | 20-44 | 5.8 61.0 40.4 86.2 | 4.4 36.4 32.1 71.1 | 3.6 37.8 26.4 59.6 | 9.7 6.2 | 5.6 | | 45-64 | 17.6 210.8 129.9 354.1 | 13.4 139.6 105.3 257.3 | 11.8 132.4 93.1 243.9 | 32.7 22.6 | 19.6 | | 65-74 | 54.1 433.6 469.9 1034.8 | 35.1 347.1 339.8 796.1 | 32.5 281.0 297.7 669.4 | 74.7 55.2 | 46.0 | | 75 plus | 81.7 542.4 812.2 1432.8 | 38.9 369.2 633.3 1050.4 | 45.6 321.9 537.1 920.4 | 103.6 60.3 | 59.0 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 7.3 65.9 65.5 138.2 | 4.6 45.2 49.8 102.1 | 4.0 39.0 39.8 83.3 | 9.2 6.0 | 5.2 | ------------------------------------------------------------------------------------------------------------------------- Glomeruloneph. ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 3.9 13.0 18.2 41.2 | 4.0 11.9 22.5 52.7 | 2.9 9.2 15.2 35.2 | 3.8 3.9 | 2.7 | | 20-44 | 11.3 51.3 67.8 147.8 | 9.2 36.0 56.4 121.5 | 7.2 32.1 44.8 98.5 | 11.8 9.1 | 7.4 | | 45-64 | 21.3 105.1 157.9 363.8 | 15.2 72.2 122.9 283.7 | 13.3 63.6 102.7 236.6 | 23.4 16.6 | 14.2 | | 65-74 | 38.9 170.5 344.8 798.2 | 24.9 126.3 255.3 509.2 | 23.0 105.9 216.7 470.7 | 41.6 28.1 | 24.9 | | 75 plus | 44.8 177.0 444.1 814.9 | 21.8 118.1 344.0 516.8 | 23.8 101.3 276.4 427.7 | 45.3 25.8 | 25.7 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 7.2 33.8 54.7 119.9 | 5.3 23.5 43.0 89.2 | 4.4 20.3 34.3 73.3 | 7.4 5.3 | 4.5 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.27 (Continued) Standard Errors For Adjusted December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD By Sex, By Race, By Age Adjusted For Age, Race, And Sex 1991-1993 Cystic Kidney ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 1.9 3.2 * * | 1.9 3.0 9.7 * | 1.3 2.2 5.5 12.9 | 1.7 1.6 | 1.2 | | 20-44 | 4.0 9.1 16.7 41.0 | 3.4 8.9 11.7 39.1 | 2.6 6.9 10.7 31.1 | 3.6 3.1 | 2.4 | | 45-64 | 14.5 46.2 66.3 176.7 | 13.3 40.2 56.8 156.8 | 10.2 32.0 48.6 122.9 | 14.3 13.0 | 9.6 | | 65-74 | 21.1 81.5 163.7 * | 19.4 61.1 130.4 273.7 | 14.1 49.9 106.1 184.1 | 21.0 18.5 | 13.9 | | 75 plus | 18.4 85.9 139.3 * | 10.9 43.1 * * | 10.0 45.2 63.1 * | 18.4 10.1 | 10.3 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 3.8 12.5 20.6 46.6 | 3.3 10.1 16.2 42.0 | 2.5 7.9 12.9 31.3 | 3.5 3.1 | 2.3 | ------------------------------------------------------------------------------------------------------------------------- Other Urologic ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 2.6 6.5 12.5 * | 1.7 2.2 * * | 1.5 3.4 6.5 12.6 | 2.4 1.5 | 1.4 | | 20-44 | 3.3 9.8 12.3 38.8 | 2.6 5.8 10.4 39.1 | 2.1 5.6 8.1 26.5 | 3.1 2.4 | 1.9 | | 45-64 | 5.1 24.4 33.1 77.8 | 4.6 17.2 25.3 * | 3.6 16.4 22.3 57.1 | 5.9 4.7 | 3.7 | | 65-74 | 15.1 81.8 126.8 * | 8.5 40.7 82.5 * | 8.8 46.6 81.4 173.6 | 17.6 9.6 | 9.8 | | 75 plus | 24.7 139.1 237.9 576.2 | 8.0 40.1 153.2 0.0 | 13.3 73.4 129.1 301.6 | 29.8 9.6 | 15.2 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 2.5 11.7 18.2 44.0 | 1.6 5.5 12.3 24.5 | 1.4 5.8 10.5 22.2 | 2.5 1.5 | 1.3 | ------------------------------------------------------------------------------------------------------------------------- Other Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 5.4 13.0 21.2 49.8 | 4.4 10.9 20.7 35.0 | 3.5 8.7 15.5 32.3 | 4.9 4.1 | 3.2 | | 20-44 | 8.1 31.8 33.5 90.8 | 8.1 33.0 41.0 91.4 | 5.7 23.4 26.8 64.8 | 8.0 8.0 | 5.7 | | 45-64 | 12.8 68.4 69.8 184.4 | 13.3 60.0 86.4 183.6 | 9.5 46.5 59.5 143.3 | 14.5 14.2 | 10.1 | | 65-74 | 28.1 144.0 187.9 488.8 | 23.0 107.6 187.3 525.9 | 18.2 90.9 136.0 365.2 | 31.2 24.8 | 19.8 | | 75 plus | 37.0 192.8 329.1 885.9 | 18.7 101.2 265.3 538.8 | 20.2 109.0 201.6 503.6 | 42.1 21.4 | 23.2 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 5.2 24.4 30.7 80.7 | 4.7 20.3 31.2 72.2 | 3.4 15.5 21.6 53.1 | 5.2 4.7 | 3.4 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.27 (Continued) Standard Errors For Adjusted December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD By Sex, By Race, By Age Adjusted For Age, Race, And Sex 1991-1993 Unknown Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 2.5 6.8 9.3 * | 2.2 4.8 11.8 * | 1.7 4.3 8.0 15.2 | 2.3 2.0 | 1.5 | | 20-44 | 5.5 24.2 30.7 75.8 | 4.9 16.6 25.1 60.8 | 3.6 15.1 20.0 49.9 | 5.7 4.7 | 3.6 | | 45-64 | 10.2 64.3 78.2 189.4 | 8.6 47.2 64.3 167.8 | 6.9 41.9 54.3 145.3 | 12.8 10.1 | 8.1 | | 65-74 | 23.1 138.6 196.0 564.4 | 16.5 108.7 168.1 520.4 | 14.3 87.9 130.9 371.8 | 27.5 21.0 | 17.2 | | 75 plus | 32.7 175.8 316.6 935.6 | 16.2 108.2 253.5 444.3 | 18.4 103.7 220.0 516.0 | 39.3 21.2 | 22.0 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 3.9 21.5 30.7 82.4 | 3.0 15.2 25.2 61.3 | 2.4 12.8 19.5 49.2 | 4.1 3.1 | 2.5 | ------------------------------------------------------------------------------------------------------------------------- Missing Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 1.3 3.9 0.0 0.0 | 1.3 3.1 * 0.0 | 0.9 2.6 * 0.0 | 1.2 1.2 | 0.8 | | 20-44 | 4.0 15.3 11.2 31.4 | 3.6 10.9 8.2 35.1 | 2.6 9.9 7.1 24.2 | 3.9 3.3 | 2.5 | | 45-64 | 8.4 55.9 18.6 101.2 | 7.3 44.2 23.4 117.8 | 5.7 38.7 17.9 86.9 | 10.6 8.9 | 6.8 | | 65-74 | 15.7 127.4 103.5 * | 12.5 105.4 79.2 330.8 | 9.9 82.4 66.1 212.4 | 21.1 17.2 | 13.5 | | 75 plus | 17.4 130.6 127.1 0.0 | 9.8 88.1 127.7 * | 9.7 74.3 97.7 * | 22.1 13.8 | 12.8 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 2.7 17.3 12.2 31.4 | 2.3 13.3 10.7 38.5 | 1.7 10.7 8.0 25.5 | 2.9 2.4 | 1.8 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.27 (Continued) Standard Errors For Adjusted December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD By Sex, By Race, By Age Adjusted For Age, Race, And Sex 1994-1996 Diabetes ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 0.5 1.9 * * | 0.6 2.5 * * | 0.4 1.6 * * | 0.5 0.6 | 0.4 | | 20-44 | 11.4 36.1 34.4 140.3 | 10.0 32.6 29.0 142.2 | 7.2 24.7 22.7 106.2 | 10.3 9.0 | 6.8 | | 45-64 | 27.9 178.9 178.9 838.2 | 24.0 162.5 139.4 804.2 | 19.9 138.4 137.0 684.1 | 37.8 33.6 | 25.2 | | 65-74 | 59.1 421.1 605.5 2070.6 | 52.6 432.8 508.9 2402.1 | 39.5 304.9 400.7 1575.1 | 78.0 75.5 | 54.3 | | 75 plus | 55.0 417.6 741.4 1680.9 | 35.4 339.7 645.6 1683.3 | 29.4 245.1 465.1 1073.3 | 69.5 54.1 | 43.7 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 8.7 54.6 71.8 252.2 | 7.4 50.7 59.7 265.0 | 5.7 37.2 46.3 185.6 | 9.4 8.2 | 6.2 | ------------------------------------------------------------------------------------------------------------------------- Hypertension ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 1.0 5.5 0.0 * | 1.3 4.4 * * | 0.8 3.6 * 15.0 | 1.1 1.2 | 0.8 | | 20-44 | 6.4 65.8 41.4 107.7 | 4.9 40.7 33.1 89.2 | 3.9 39.2 26.6 72.8 | 10.1 6.6 | 5.9 | | 45-64 | 18.5 219.3 134.7 379.3 | 13.7 141.9 110.1 282.1 | 12.7 140.8 100.5 259.8 | 35.1 24.0 | 20.9 | | 65-74 | 58.1 468.0 491.9 1132.8 | 38.2 372.8 354.6 901.8 | 34.9 304.2 309.9 736.0 | 80.5 59.6 | 49.6 | | 75 plus | 87.9 594.3 864.1 1335.0 | 43.4 399.9 624.9 1115.1 | 49.6 355.3 544.9 876.3 | 112.3 65.8 | 64.1 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 7.8 70.3 68.5 142.7 | 4.9 48.1 50.9 113.6 | 4.3 41.5 41.3 90.0 | 9.8 6.4 | 5.6 | ------------------------------------------------------------------------------------------------------------------------- Glomeruloneph. ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 4.0 14.4 19.5 46.3 | 4.1 12.1 21.7 56.3 | 2.9 9.6 15.4 37.6 | 4.0 3.9 | 2.8 | | 20-44 | 12.0 54.3 71.1 155.7 | 9.7 40.1 60.9 138.6 | 7.5 33.9 47.0 106.3 | 12.3 9.7 | 7.8 | | 45-64 | 22.0 114.2 156.8 377.8 | 15.9 75.7 121.9 303.1 | 14.1 69.4 103.8 255.7 | 25.1 17.6 | 15.2 | | 65-74 | 41.8 185.5 382.2 791.5 | 27.1 134.8 246.0 598.4 | 24.8 115.6 230.8 490.6 | 45.0 30.2 | 26.8 | | 75 plus | 48.1 197.8 501.1 1052.8 | 23.0 124.2 362.7 536.2 | 25.9 111.1 299.1 519.0 | 50.3 27.1 | 28.2 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 7.6 36.0 58.0 128.8 | 5.5 25.1 43.9 99.0 | 4.6 21.6 35.5 79.3 | 7.8 5.6 | 4.7 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. *Values for cells with fewer than 10 patients are suppressed. Table B.27 (Continued) Standard Errors For Adjusted December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD By Sex, By Race, By Age Adjusted For Age, Race, And Sex 1994-1996 Cystic Kidney ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 1.9 3.5 * 24.9 | 1.9 4.1 11.9 * | 1.3 2.7 7.0 13.5 | 1.7 1.7 | 1.2 | | 20-44 | 4.2 9.8 13.9 46.5 | 3.6 9.8 13.1 41.6 | 2.7 7.1 9.8 32.8 | 3.6 3.2 | 2.4 | | 45-64 | 15.0 47.6 69.0 175.8 | 13.5 41.0 49.9 162.8 | 10.7 34.0 47.1 132.2 | 15.1 13.5 | 10.1 | | 65-74 | 23.9 85.6 159.4 274.7 | 21.3 68.3 115.9 286.0 | 15.9 54.7 98.2 192.9 | 23.4 20.2 | 15.4 | | 75 plus | 19.4 88.9 182.1 * | 12.2 53.7 135.5 * | 10.7 49.9 95.4 139.2 | 19.8 12.0 | 11.4 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 4.0 13.1 21.3 48.7 | 3.5 10.9 16.2 44.5 | 2.6 8.3 13.1 32.9 | 3.7 3.2 | 2.4 | ------------------------------------------------------------------------------------------------------------------------- Other Urologic ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 2.7 7.4 10.7 * | 1.8 2.8 * * | 1.6 3.9 5.8 * | 2.5 1.6 | 1.4 | | 20-44 | 3.8 10.7 14.4 45.3 | 3.2 6.8 11.4 41.6 | 2.5 6.3 9.1 30.3 | 3.5 2.9 | 2.2 | | 45-64 | 5.8 24.9 35.8 89.5 | 5.2 17.5 32.4 * | 4.2 16.9 28.3 61.1 | 6.6 5.3 | 4.2 | | 65-74 | 16.3 82.8 113.4 288.1 | 9.9 44.0 89.4 * | 9.6 47.7 73.3 170.6 | 18.2 10.6 | 10.4 | | 75 plus | 25.9 130.7 237.5 642.6 | 8.9 43.5 116.0 * | 13.9 75.2 132.9 351.4 | 31.0 9.9 | 15.8 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 2.7 11.9 18.4 49.7 | 1.9 6.0 12.3 25.7 | 1.6 6.0 10.4 24.7 | 2.7 1.7 | 1.5 | ------------------------------------------------------------------------------------------------------------------------- Other Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 5.7 14.7 21.7 47.5 | 4.5 11.6 19.3 47.7 | 3.6 9.4 15.2 34.3 | 5.2 4.2 | 3.3 | | 20-44 | 8.8 36.4 34.1 108.9 | 8.7 37.8 41.1 103.1 | 6.1 26.3 26.9 75.7 | 8.8 8.7 | 6.2 | | 45-64 | 13.8 74.7 67.4 240.0 | 14.0 64.0 83.6 205.8 | 10.3 50.8 58.3 170.9 | 16.0 15.1 | 11.0 | | 65-74 | 31.5 148.7 202.5 589.2 | 25.4 114.9 176.8 563.1 | 20.2 96.0 135.4 405.0 | 33.9 26.9 | 21.5 | | 75 plus | 41.7 199.1 317.2 820.8 | 21.3 110.8 228.1 459.8 | 23.3 114.7 193.7 481.9 | 45.9 23.4 | 25.4 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 5.7 26.3 30.6 91.4 | 5.0 22.3 29.8 76.8 | 3.7 16.9 21.0 58.2 | 5.7 5.0 | 3.7 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.27 (Continued) Standard Errors For Adjusted December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD By Sex, By Race, By Age Adjusted For Age, Race, And Sex 1994-1996 Unknown Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 2.4 7.2 7.1 24.9 | 2.2 5.5 9.2 * | 1.7 4.6 6.3 16.5 | 2.2 2.1 | 1.5 | | 20-44 | 5.9 25.5 30.9 79.3 | 5.2 17.8 25.3 66.1 | 3.8 15.6 19.9 52.2 | 5.9 4.9 | 3.8 | | 45-64 | 10.2 63.5 75.1 183.2 | 8.5 45.4 62.9 158.8 | 7.0 41.4 54.7 133.8 | 12.9 10.1 | 8.1 | | 65-74 | 23.4 138.3 203.3 582.8 | 17.0 106.0 171.0 452.3 | 14.5 88.2 134.6 366.2 | 27.9 21.0 | 17.3 | | 75 plus | 33.1 169.7 332.5 722.2 | 16.7 110.7 266.4 431.3 | 18.7 100.8 203.9 400.5 | 37.8 22.1 | 21.6 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 4.0 21.4 30.6 76.1 | 3.1 15.2 25.4 58.4 | 2.4 12.8 19.7 46.8 | 4.1 3.1 | 2.5 | ------------------------------------------------------------------------------------------------------------------------- Missing Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 1.6 5.1 * * | 1.5 4.8 * 0.0 | 1.1 3.5 * * | 1.5 1.4 | 1.0 | | 20-44 | 3.8 14.3 12.4 32.9 | 3.5 10.8 9.0 28.9 | 2.5 9.0 7.7 22.3 | 3.6 3.1 | 2.4 | | 45-64 | 7.3 44.2 23.6 95.7 | 6.0 29.6 22.1 64.8 | 4.8 29.2 18.6 70.4 | 8.8 6.7 | 5.5 | | 65-74 | 11.7 91.5 86.3 * | 9.1 74.8 46.7 237.2 | 7.3 58.4 47.9 132.5 | 15.4 12.2 | 9.7 | | 75 plus | 11.3 91.0 * 0.0 | 6.9 59.6 92.5 * | 6.6 53.0 64.3 * | 15.0 10.0 | 8.9 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 2.3 13.5 9.9 26.2 | 2.0 9.7 8.8 27.0 | 1.5 8.1 6.8 19.3 | 2.4 2.0 | 1.5 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Reference Tables: Prevalence Of Reported ESRD Therapy USRDS 1998 Annual Data Report USRDS 1998 Annual Data Report Reference Tables: Prevalence Of Reported ESRD Therapy B.2 USRDS Patient Database Updated From HCFA REBUS September 1997. Quality Control Filters Applied. See section introduction and Chapter XIII discussion of the database and of the methodologies used. USRDS Patient Database Updated From HCFA REBUS September 1997. Quality Control Filters Applied. B.1 See section introduction and Chapter XIII discussion of the database and of the methodologies used.